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ABSTRACT
Fibrin fibers are an essential component of blood clots. They provide structural support
and prevent embolism. Formation of fibrin fibers is initiated by the enzyme thrombin, which
is a product of the coagulation cascade. It converts fibrinogen into fibrin monomers. Fibrin
monomers polymerize to form half-staggered protofibrils that laterally aggregate to form
fibrin fibers. Fibrin fibers form a mesh or gel-like structure over an injury zone and in and
around platelet aggregates. It is known that the structure of fibers are dependent on the
conditions in which they are formed.
We present a two-dimensional mathematical model of fibrin polymerization in flow with
feedback on the fluid. We include a spatial-temporal source of fibrin monomers from a
simplified coagulation scheme. In the model, fibrin polymerizes by forming linear bonds
between any two oligomers and by forming branch points between any three oligomers.
Because we want to track oligomer concentrations composed of any number of monomers
and branch points, we have a doubly infinite set of PDEs which include diffusion and
advection of oligomers. Using a generating function and a change of variable, we find a
closed system of equations to study fibrin gelation and postgelation dynamics. The model
tracks both branch point and fibrin mass densities of the gel which are used to calculate
a distribution of fiber diameters and pore sizes. The permeability of the gel, which is
calculated from the volume fraction of fibrin and the fiber diameters, is used to hinder the
fluid velocity through a Brinkman term. We vary model parameters, such as the thrombin
production rate and the rate of branch point formation, to find what effect this has on clot
structure.
We also present two model modifications. We alter the model to include thrombin
production on three different distributions of platelet aggregates. We also modify the model
to include hindered transport on all proteins. The diffusivity and advection of oligomers
and coagulation proteins are dependent on the amount of gel at each spatial locations. An
additional velocity term is included that moves proteins from areas of high volume fraction
of gel to areas of low gel volume fraction of gel.
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CHAPTER 1
INTRODUCTION
Coagulation is an essential process that allows animals to maintain healthy vasculature.
The process is a complicated cascade of proteolytic reactions that results in a blood clot
or thrombus. When an injury occurs, the subendothelium exposes tissue factor that initi-
ates the cascade [34]. Platelets and zymogens circulating in the blood become activated.
Platelets cover the injury zone and act as a surface for reactions. One essential reaction
results in the coagulation enzyme thrombin. Thrombin is responsible for converting the
zymogen fibrinogen into the active form, fibrin. Fibrin polymerizes to form fibrin fibers
that make a gel-like network over the injury and bound platelets. This composition is
defined as a thrombus. Following formation, fibrinolysis breaks down the fibrin fibers and
dissolves the clot.
Coagulation requires a balance between inhibition, activation, and fluid dynamics. An
excess of fibrin gelation can lead to difficulties in fibrinolysis, while too little fibrin can
cause embolism. The properties of a fibrin gel, including fiber diameter and porosity, are
determined from the conditions during polymerization.
In this dissertation, we examine the process of fibrin clot formation. In the remainder
of this chapter we discuss the biological background and previous fibrin polymerization and
gelation models. In Chapter 2, we derive a 2-D mathematical model of fibrin gelation in
flow. In Chapter 3, we discuss the results, parameter explorations, and implications of the
model. In Chapter 4, we present an expanded model that includes more biologically realistic
coagulation dynamics. In Chapter 5, we present a modified model that incorporates the
effect that fibrin gel has on transport. Chapter 6 contains a description of the numerical
methods used to simulate the models.
1.1 Fibrin Polymerization
Fibrin polymerization is the process in which fibrin monomers become a gel of fibrin
fibers. The process begins at the end of the coagulation cascade where the zymogen
prothrombin (Factor II) is converted to the enzyme thrombin (Factor IIa) by the prothrom-
2binase complex. Prothrombinase is located on the membrane of platelets and is comprised
of Factor Xa and the cofactor, Factor Va.
Prothrombin is carried in the blood at a concentration around 1.4 µM [26]. Prothrombin
binds to specific sites on activated platelet. Activated platelets have binding sites for
many different coagulation proteins. Factor Va and Xa can also bind to specific sites
on the membrane of platelets and join together to form a complex called prothrombinase.
Platelet-bound prothrombin binds to prothrombinase and prothrombinase prothrombin to
thrombin. Prothrombin can be converted to thrombin in the plasma by Xa. However, this
reaction is 4-5 orders of magnitude slower than the conversion of platelet bound prothrombin
by prothrombinase [27]. Thrombin is inhibited by antithrombin in order to prevent fibrin
monomer production away from an injury.
Fibrinogen is a soluble glycoprotein present in human blood plasma at a concentration of
2.5 g/L [35]. Fibrinogen molecules are 45 nm long and symmetrical. Each half is composed
of 3 peptide chains (Aα, Bβ, and γ). The 3 peptide chains are coiled around each other.
The two halves of fibrinogen are connected at the central nodule. The N-termini of the
Aα and Bβ peptide chains (near the central nodule) contain fibrinopeptides A (FpA) and
fibrinopeptides B (FpB) [8]. In order for polymerization to begin, thrombin must cleave
FpA from fibrinogen. Thrombin also cleaves FpB. The cleavage events expose knob ‘A’ and
knob ‘B’ on the N-termini of the α and β chains, respectively. These sequences bind to ‘a’
holes and ‘b’ holes in the γ chain on the end of a different fibrin(ogen) molecule. While FpA
and FpB can be cleaved at different times, in solution FpA is cleaved first. It is sufficient
for only FpA to be cleaved in order for fibrin to form protofibrils [36], [39].
Once thrombin has converted fibrinogen into fibrin monomer, fibrin polymerization
begins. Monomers bind center to end. Therefore, fibrin polymerization yields half-staggered
protofibrils with a repeat unit of 22.5 nm [37]. Fibrin oligomers are defined to be protofibrils
when they reach a length of 0.5−0.6µm, which corresponds to 20-25 monomers [6]. At this
length, protofibrils can laterally aggregate to form fibrin fibers. The exact mechanism for
lateral aggregation is still unknown. However it is known that protofibrils will twist around
each other during fiber formation. FpB cleavage might play a role in this process [36].
Fibrin fibers contain two types of branches, bilateral junctions and equilateral junction.
Bilateral junctions are formed by two protofibrils laterally aggregating and then separating
again to form a branch. The second type of branch is called an equilateral junction which
is formed when three fibrin monomers bind together to form an equilateral triangle [28].
Experiments in static conditions have studied the effects of thrombin concentration on
3fibrin polymerization. These studies showed that higher concentrations of thrombin form
thin fibers with more branches (as compared to lower concentrations of thrombin, which
form thick fibers with few branches)[38].
Once there is a three-dimensional network of fibers (branched and unbranched) that
behaves like a solid, the clot is formed. This is also known as reaching the gel point. Even
though the gel has formed, fibers can continue to thicken, grow longitudinally, and add
branches [7].
It is important to study fibrin polymerization in blood flow in order to understand how
clots are formed physiologically. There are several key differences between forming a clot
in flow and forming a clot in static conditions. Because flow is continuously supplying
fibrinogen to the injury site, clots formed in flow tend to have thicker fibers [29]. Similarly,
fibrin is constantly being carried out by the fluid. Therefore, fibers have to form and adhere
to platelets or subendothium before the flow carries them out. In the same way that the
fluid can affect the clot formation, the gel structure can affect the fluid motions.
While most experiments on fibrin clot formation have been performed in static condi-
tions, researchers have recently found techniques to study clot formation in flow. One result
from the flow experiments by Wolberg and Weisel (independently) showed that fibrin fibers
tend to align in the direction of flow [5] [13]. Even at a low shear rate of 5 s−1 (venous
flow is around 100 s−1), fibers begin to align. At slightly higher (but still considered low)
shear rates, thick fibers are almost completely aligned in the direction of flow. Thin fibers
that are perpendicular to the flow serve as connectors between the thicker fibers. Blood
clots have also been studied in vivo. Clots formed in veins are fibrin-rich. In arteries, where
high shear rates are experienced, clots tend to be platelet-rich with fibrin-rich areas only on
the downstream end of the clot (where lower shear rates are experienced due to platelets
hindering the flow) [40].
1.2 Previous Models
One of the first mathematical models used to study fibrin polymerization was by Hant-
gan and Hermans in 1979 [15]. They were able to show from their model, along with
experimental data, that fibrin polymerization does not require nucleation, i.e., there is not
a separate slow nucleation process to start a protofibril. In 1992, Weisel and Nagaswami
created one of the first computational models of fibrin polymerization [38]. The model
consists of a set of ODEs that explicitly models monomers binding to oligomers, oligomers
transitioning to protofibrils, and collections of protofibrils becoming fibers. This model is
4able to reproduce lag times seen in experiments between initiation and formation of a fibrin
network. It also makes predictions about the effect kinetic rate constants have on fiber size
and length.
In order to create models that include reactions between any size oligomers, researchers
began using the mathematical framework introduced by Ziff and Stell to study the dynamics
of condensation reactions and gelation [42]. Published in 1980, the Ziff-Stell model uses an
infinite set of Smoluchowski coagulation equations which describe changes in the concen-
tration of any size oligomer due to polymerization. The system of ODEs includes binding
of any two size oligomers. Using a generating function to transform the set of ODEs to a
single PDEs and single ODE, they were able to identify a mathematical singularity that
indicates the transition from oligomers to gel and the time this transition occurs. They also
extended their general polymerization model to include postgelation dynamics. In 2007,
Guy et al. used the frame work presented in the Ziff-Stell model to study fibrin gelation
[14]. They coupled a modification of the condensation reaction to include a sink (advection)
and a source of fibrin monomers with a simplified coagulation cascade and a shear flow. The
model answers the question, how tall will a fibrin gel grow in flow? While the model itself is
actually quite simple, it is able to study key dynamics of fibrin gelation including thrombin
inhibition, effects of fluid flow, and gel permeability.
Fogelson and Keener modified the Ziff-Stell model to include two types of reactions,
branch point formation and linear reaction [11]. We will refer to this model as the ‘Branching
Model’. The original model consists of a doubly infinite set of ODEs for the concentration
of oligomers with a different number of branch points and monomers units. The model is
reduced to a small set of ODEs for physically-interesting quantities such as concentration of
branch points by expressing them as moments of the oligomers concentrations. While the
Branching Model does not include the formation of bilateral junctions or lateral aggregation
of protofibrils, it does include the formation of equilateral junctions. The Branching Model
supplies fibrin monomers at a constant rate and tracks the concentration of reactive sites
and branch points, as well as fibrin mass until gel time. By tracking the concentration
of branch points, the model is able to predict structure of the oligomers. While the
Branching Model initially wrote the condensation reactions as ODEs, it is easily extended to
a spacial-temporal model that includes advection of oligomers coupled with fluid dynamics.
Also, the model only tracks concentration until gel time and therefore does include any gel
formation or postgelation dynamics. These limitations led Fogelson and Keener to revisit
the Ziff-Stell model and create a systematic way of including and studying postgelation
5dynamics [12].
In Fogelson et al. [12], they begin with general condensation equations that include
sources, sinks, and diffusion and apply the same generating function as Ziff-Stell [12]. They
show that under the correct change of variables, one can find a closed system of equations
that model monomers polymerizing into a gel. They also provided an approach that tracks
structural properties of the gel and the oligomers in the solvent. We use the approach
that was first presented by Ziff-Stell and modified in Guy et al., the Branching Model,




We consider a rectangular domain, x ∈ [0, Lx1 ] × [0, Lx2 ], that represents a segment of
a blood vessel. The top and bottom, x2 = 0 and x2 = Lx2 , represent the vessel walls.
We assume that blood flows into the vessel at x1 = 0 with a specific profile and leaves
the vessel at x1 = Lx1 . An injury zone is located at the center of the lower vessel wall at
[L1, L2], where 0 < L1 < L2 < Lx1 . A depiction of the domain is shown in Figure 2.1. We
have three types of species, coagulation chemicals, fibrin oligomers, and fibrin gel. Due to
the complexity of coagulation, we use a simplified system involving only three coagulation
proteins, prothrombin, thrombin, and fibrinogen. We assume that prothrombinase is located
along the injury zone and converts prothrombin to thrombin. Fibrin oligomers polymerize
through either linear or branching reactions, eventually forming a fibrin gel. Fibrin gel is
immobile and remains where it is formed. Due to its structure, the gel can affect blood flow
and diffusion of other species.
2.1 Coagulation Proteins
Our simplification of the coagulation cascade involves only three species. Prothrombin,
which is present in the blood, is converted to thrombin on the injury zone by prothrombinase.
Fibrinogen, which is also present in the blood, is cleaved by thrombin to produce fibrin
monomer. There are several different thrombin inhibitors present in the blood and this is
represented by a single degradation term. Let Z2 represent the zymogen prothrombin (be-
cause prothrombin is also known as Factor II), E2 the enzyme thrombin, and F fibrinogen.
Let z2, e2, and f denote their respective concentrations. We track the concentration of all
three species as they diffuse, advect, and react at points x at time, t, by these equations
∂z2
∂t
+∇ · (uz2) = ∇ · (Dz∇z2) (2.1)
∂e2
∂t
+∇ · (ue2) = ∇ · (Dz∇e2)− kate2 (2.2)
∂f
∂t
+∇ · (uf) = ∇ · (Df∇f)− kfe2f
kfs + f
. (2.3)







Figure 2.1: Model domain includes an injury zone located in the center along the bottom
wall.
8saturation concentration, and kf is the reaction rate for fibrinogen cleavage. Because
thrombin is a cleaved form of prothrombin, we assume that they have the same diffusivity,
Dz and fibrinogen has diffusivity Df .
The injury zone contains a density of wall-bound prothrombinase. We assume that
prothrombin can diffuse and advect to the wall and bind to and unbind from prothrombinase.
While bound, prothrombin can be cleaved to become thrombin. When this happens,
thrombin is immediately released into the fluid. We also assume that the prothrombin-
prothrombinase system is in quasi-steady state. (A dynamic version of this system will be
discussed later.) The quasi-steady state relations lead to the boundary conditions for z2
and e2 in the injury zone. The complete set of boundary conditions for z2, e2, and f are as
follows.
For z2,
z2(0, x2, t) = z
up
2 ,
∂z2(Lx1 , x2, t)
∂x1
= 0,
∂z2(x1, Lx2 , t)
∂x2
= 0, (2.4)




0, for x1 < L1, x1 > L2
−αz2
β+z2
, for L1 ≤ x1 ≤ L2.
(2.5)
For e2,
e2(0, x2, t) = 0,
∂e2(Lx1 , x2, t)
∂x1
= 0,
∂e2(x1, Lx2 , t)
∂x2
= 0, (2.6)




0, for x1 < L1, x1 > L2
αz2
β+z2
, for L1 ≤ x1 ≤ L2.
(2.7)
For f ,
f(0, x2, t) = f
up,
∂f(Lx1 , x2, t)
∂x1
= 0, (2.8)
∂f(x1, Lx2 , t)
∂x2
= 0, −Df ∂f(x1, 0, t)
∂x2
= 0.
Here, α is a function of the cleavage rate and the concentration of prothrombinase, while β
is a function of the binding, unbinding, and cleavage rates. The coagulation proteins yield




2.2 Fibrin Oligomers and Gel
Once fibrin monomers are produced from the coagulation protein, they spontaneously
polymerize. The polymerization process yields a fibrin gel. In order to model the formation
of a gel, we begin with the condensation reactions of fibrin oligomers. Describing these
reactions leads to a doubly infinite set of partial differential equations for concentrations
9of oligomers of all sizes and number of branches. Next, we use a generating function to
transform the doubly infinite set of PDEs to a system of two PDEs. We next explain how
these equations are modified to capture our assumption about reactions involving the gel.
Finally, we derive equations that allow us to track structural quantities such as branch point
density and mass of fibrin. The boundary conditions for the gelation PDEs are discussed
at the end of this section.
2.2.1 Fibrin Condensation Reaction
We assume fibrin polymerizes in two ways, through linear reactions and branching
reactions as in [11]. There are two steps to each of these reactions. First, two fibrin
monomers bind center to tail; then they can either “zip” together to complete a linear
reaction or another monomer can join in a branching reaction. This is depicted in Figure
2.2. We do not explicitly track the two steps, but instead postulate a rate of linear reaction
that is a reaction involving two reaction sites on oligomers and a rate of branching that
involves three such reactive sites. In general, we want to consider oligomers of any size
with any number of branch points. For integers, m = 1, 2, . . . and b = 0, 1, . . . , let Cm,b
denote an oligomer with b branch points and m + 2b monomers and let cmb denote the
concentration of these oligomers. For example, using this naming convention, monomers
are C1,0 and oligomers with three branch points and eight monomers are C2,3. We track
the concentration cmb using the following condensation equation:
∂cmb(x, t)
∂t






























(b1 + 2)(b2 + 2)cm1b1cm2b2
+ Smb.
Here kl is the rate of linear binding and kb is the rate of branch point formation. The first line
of 2.9 describes changes due to advection and diffusion. Note that the diffusion coefficient
can be different for each oligomer. The second line of 2.9 describes the linear reaction of
two appropriate size oligomers that bind to form an oligomer of size cmb. Oligomers cmb
10
Figure 2.2: Linear and branching binding diagram. Fibrin monomers can polymerize
in one of two ways: 1) Linear Binding, where two monomers zip together to form a linear
oligomer and 2) Branching Reaction, where three monomers come together to form a branch
point.
11
have b + 2 end points or reactive sites and we assume that the rate of linear binding of
two types of oligomers is proportional to the product of concentrations of reactive sites on
each. The third line of 2.9 describes the rate at which three appropriately sized oligomers
coming together to form an oligomer of Cmb. The fourth line of 2.9 describes Cmb oligomers
binding with any two oligomers to form a branch point. The final line is the source rate
Smb. The only source in the system is for fibrin monomers at a rate S10 and describes the
thrombin-mediated conversion of fibrinogen to fibrin monomers.





We can rewrite equations 2.9 as
∂cmb(x, t)
∂t








(b1 + 2)(b2 + 2)cm1b1cm2b2















The boundary conditions for cmb are
cmb(0, x2, t) = 0,
∂cmb(Lx1 , x2, t)
∂x1
= 0, (2.12)
∂cmb(x1, Lx2 , t)
∂x2




Equations 2.11 and 2.10 describe the process of polymerization but only describe reac-
tions among finite length oligomers. We want to extend the reactions beyond a time when a
gel forms (described below). For now suppose there is a gel and that Rg is the concentration
of reactive sites in it. Then we modify equation 2.11 to allow for reaction involving reactive



































The fourth line of 2.13 describes linear binding of the Cmb oligomer with the gel. The
seventh line of 2.13 describes Cmb oligomer binding with a reactive site in the gel and with
another oligomer to form a branch point. Notice that equation 2.13 does not allow for any
rings or loops to form (i.e., two reactive sites on the same oligomer cannot bind together
and two gel reactive sites cannot bind together).
Equation 2.13 is a doubly infinite system of PDE’s. To study it, we follow the approach
in [42] and [11] and introduce a generating function which is a power series in two dummy
variables y and z with the concentration cmb(x, t) as coefficients.




Values of g(x, t, y, z) for z values between 0 and 1 at y values near y = 1 are all that will
be needed below. Under the assumption that all finite-sized oligomers advect and diffuse
the same, equation 2.13 can be used to show that the generating function satisfies the PDE
∂g
∂t



























where R ≡ Rs +Rg. We assume that once gel is created it is stationary, it neither advects
nor diffuses. Then R evolves because of advection and diffusion of finite sized oligomers











R3 − (3RsR2g +R3g))+ 2S10
The first term in the second line of 5.19 describes the rate that reactive sites are lost due
to linear reactions. Linear reactions cannot occur between two gel reactive sites. Therefore
it is subtracted off. The second term describes the rate reactive sites are lost due to branch
point formation. Again, reactive sites in the gel cannot react so the terms must be subtracted
off.
We perform a change of variables
W˜ (x, t, y, z) = gz(x, t, y, z)− zR(x, t). (2.17)
From equations 2.15 and 5.19,
∂W˜
∂t



































(−zR3 + 3zRsR2g + zRg3)+ kb2y2 z2R3.
For reasons explained below, define V˜ (x, t, y, z) = W˜y(x, t, y, z). It turns out that only
values of W˜ and V˜ for y = 1 are needed. So let W (x, t, z) = W˜ (x, t, y = 1, z) and




from the definition of g, we see gz
∣∣
y=z=1
= Rs. And implies W (x, t, 1) = Rs −




. From 2.18, we can deduce that
∂W
∂t
= − ∇ · (u (W − zW ∣∣
z=1
))












































We are interested in tracking the concentration of branch points of finite size oligogmers
in the sol and the concentration of branch points in the gel as well as the concentration




bcmb which can be rewritten in terms of g and W ,
Bs = gz(t,x, 1, 1)− 2g(t,x, 1, 1) (2.21)
= W (t,x, 1)− 2
∫ 1
0
W (t,x, z′)dz′. (2.22)
Let B = Bs + Bg, where Bg is the concentration of branch points in the gel. Since gel is
fixed, B evolves according to
∂B
∂t
= −∇ · (uBs) +∇ · (Dc∇Bs) + kb
6
(
R3 − (3RsR2g +R3g)) , (2.23)
and we can compute Bg by Bg = B − Bs. The reaction term in 2.23 is the rate of branch
point formation. One way to explain the coefficient of 1/6 is using equation 5.19. For
every branch point formed, there is a loss of three reactive sites. The rate of branch point
formation is a third of rate of reactive site lost due to such reaction.
The mass density of fibrin, θs, in the sol is defined as θs =
∑
mb(m + 2b)cmb, i.e., the
total number of monomer unites in finite size oligomers. It can be described in terms of g,
W , and V ,




V (x, t, z′)dz′ + 2W (x, t, 1)− 4
∫ 1
0
W (x, t, z′)dz′. (2.25)
We let the total mass density of fibrin be defined as θ = θs + θg, where θg is the mass
density of fibrin in the gel. Since θg is stationary, θ evolves according to
∂θ
∂t
= −∇ · (uθs) +∇ · (Dc∇θs) + S10. (2.26)
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2.2.4 Boundary Conditions for Gelation Equations
The boundary conditions of the gelation the state variables, W , V , R, B, and θ, depend
on the boundary conditions of cmb. Since all oligomers are created within the domain, the
upstream concentration of the state variables is zero,
W (0, x2, t, z) = V (0, x2, t, z) = R(0, x2, t) = B(0, x2, t) = θ(0, x2, t) = 0 (2.27)
From the downstream boundary conditions for cmb, we see that homogenous Neumann
conditions hold at x1 = Lx1 for all state variables. From the definitions of W and V ,
W (x, t, 0) = V (x, t, 0) = 0. No boundary conditions are (or can be) imposed on W and V
at z = 1 because advection of W and V in z is from left to right.
The derivation of the boundary conditions along the top and bottom walls is more
complicated. Recall that we assume that there is no flux of oligomers through the vessel
walls. Further, the velocity u at which oligomers advect vanishes at these walls. Therefore,




The total concentration of reactive sites, R, is the sum of the concentrations of reactive
sites in the gel, Rg and reactive sites in the sol, Rs. Because reactive sites in the gel do not
advect or diffuse, the total flux of reactive sites must be equal to the flux of reactive sites
in the sol. Therefore,
Rt = −∇ · JR + Reactions (2.29)
= −∇ · JRs + Reactions (2.30)
This observation was used already in equation 5.19. Because Rs advects and diffuses, JRs
is described by
JRs = uRs −Dc∇Rs. (2.31)
At the wall, u, is zero so the advective flux here vanishes. From the definition, Rs =∑














This implies JRs = 0 along these walls. However, for equation 5.19, we need a boundary
condition on R. Substituting Rs = R − Rg into equation 2.31 , u = 0, and ∂Rs∂x2 = 0 along







for (x1, 0, t) and (x1, Lx2 , t).
The boundary conditions for W along the top and bottom wall can be derived similarly.





W − zW ∣∣
z=1
))− (Dc∇ (W − zW ∣∣z=1)) . (2.35)
Again, u = 0 along the top and bottom wall so the advection term vanishes. We use the
definition of W to find the boundary value of the second flux term. Recall that W = W˜
∣∣
y=1









From equation 2.34, ∂R∂x2 =
∂Rg
∂x2


























The boundary condition for V along the top and bottom wall can be derived from its
definition. Recall that V˜ = W˜y. From equation 2.17,
W˜y = gzy (2.39)

















The boundary conditions for branch points, B, and total mass, θ, are derived in a similar













We model the fluid velocity using modified Navier-Stokes equations for incompressible
fluid
ρ (ut + u · ∇u) = −∇p+ µ∆u− µα1(φg, Bg)u, (2.43)
∇ · u = 0. (2.44)
Here u(x, t) and p(x, t) are the fluid velocity and pressure at position x, at time t, re-
spectively, and ρ and µ are the fluid mass density and the dynamic viscosity of the fluid,
respectively. The term −µα1u is called a Brinkman term. Along the top and bottom wall, u
is subject to no-slip boundary conditions. Poiseuille flow is prescribed as an inflow condition
and a homogenous Neuman condition is prescribed on u for the outflow condition.
In adding the Brinkman term to the Navier-Stokes equations, we are modeling the gel
as a porous medium which imposes a drag force on fluid moving through it. Porous media
with high value of α1, offer more resistance to a given flow and are less permeable. We
chose α1, so that it increases as the local gel volume fraction increases. We assume that the
Brinkman term is also a function of branch point concentration and that the permeability
decreases with increasing branch point density.
We seek to relate the resistant coefficient α1 to the state variables θg and Bg which
describe the local structure of the gel in our model. There is a large literature regarding flow
through porous media made up of distributions of fibers. In these works, the permeability
K (the reciprocal of the resistance coefficient α1) is related to the volume fraction φg of
the fibrous material and the typical fiber diameter a. These relationships are obtained
by analysis of simplified fiber arrangements and/or empirical measurements in real fibrous
media. Jackson and James [18] gave a review of this literature including several relationships
between permeability and fiber volume fraction and diameter. While these relationships
were obtained from pertubation theory assuming the volume fraction of fiber is small,
comparisons with data from porous media shows these relationships hold for volume fraction
up to φg = 0.3. The different fiber arrangements yield the same relationships to leading
order. Therefore, we choose to use the relationships describing permeability of a porous












Here a is the diameter of the fiber. To make use of this formula we define the gel volume
fraction to be
18
φg = NaVfθg. (2.46)
The term Na is Avogadros number and Vf is the volume of a single fibrin monomer. After
making several geometric assumptions, the pore size of the gel P , and the diameter of the













−33/4pi+3φg . The derivation of fiber diameter
and pore size can be found in Appendix A.
2.3 Summary
The model consists of three coagulation proteins z2, e2, and f that produce a source rate
of fibrin monomers, then two gelation variables, W and R, describe monomers polymerizing
to form fibrin oligomers then gel, and three structural variables, V , θ, and B, describe how
the gel is changing over time. These reactions occur in fluid that is modelled using the
modified Navier-Stokes equations that includes feedback from the fluid through a Brinkman
term. Next we describe the results of simulating this model.
CHAPTER 3
RESULTS
Using the model described in Chapter 2, we want to examine the process of fibrin clot
formation. We look at three model scenarios, no flow, flow, and protected flow. Within the
first and third scenarios, we explore the rate of branch formation and the rate of thrombin
production, and we vary the upstream fibrinogen concentration.
We look at events in a blood vessel segment of length 400µm and height 100µm. The
injury zone is located in the center of the lower wall and is 80µm long. The simulations
begin with prothrombin and fibrinogen having homogenous concentrations equal to their
upstream concentrations. The initial boundary conditions must be consistent with these
initial conditions. While this is trivial for most boundary conditions, the nonlinear Robin
boundary condition for z2 requires an initialization period. At t = 0, we set α = 0. The
rate α is then increased for the first 50 s by which time it reaches the desired value.
3.1 No Flow
We begin by looking at fibrin formation when the fluid velocity is identically zero.
Prothrombin and fibrinogen are initially uniformly distributed in the domain. Prothrombin
is converted to thrombin on the injured wall and then diffuses away from that wall. Fibrin
monomer is produced where fibrinogen and thrombin co-exist. Figure 3.1 shows the throm-
bin and fibrinogen concentrations, and monomer source rate at t = 100 s. At this time,
thrombin is concentrated near the lower wall and fibrinogen is depleted there. As a result,
the largest source rate occurs away from the wall at the left and right edges of the injury
zone. In fact this is true for all time. Figure 3.2 shows snapshots in time of the fibrin source
rate. To orient the reader, the injury zone is marked in red. Initially there is no source.
As thrombin diffuses outward and fibrinogen is depleted from the region near the wall,
fibrin monomer is produced further from the injury. This occurs until the fibrinogen above
the injury zone is sufficiently depleted, and then substantial fibrin monomer production
is limited to the left and right edges of the injury and the source strength decreases with























































Figure 3.1: Fibrin monomer production without flow. The top plot is the thrombin
concentration distribution (e2) in (µM). The middle plot is the fibrinogen concentration
distribution (f) in (µM). The bottom plot is the fibrin monomer production rate, (S10)






















































































































































































distribution of the branch point and fibrin mass density and, in turn, they affect the pore
size and fiber diameter.
The gel first forms above the injury zone and then grows radially. The gel or clotting
time at each spatial location is shown in Figure 3.3.
The high initial fibrin source above the injury site causes a high concentration of sol
branch points to form there that eventually become incorporated in the gel. Figure 3.4
shows that at t = 500 s, most of the branch points are contained in the gel. The fibrin mass
density however has a very different distribution profile. Because fibrin is supplied to the
outer edges of the injury zone at a high rate, fibrin continues to bind even after a gel has
formed. This leads to a higher density of fibrin in the lower left and right edges of the gel,
as shown in Figure 3.4. Eventually, the fibrinogen is depleted from the right side of the
domain but because the boundary condition on f at x1 = 0 is f = f
up, fibrinogen diffuses
from that boundary leading to an asymmetrical gel.
The variability in the distributions of fibrin mass and branch points in the gel leads
to a wide range of pore sizes and fiber diameters. Figure 3.5 shows that the highly
branched portion of the gel that is located near the wall has smaller fiber diameters than
elsewhere. This is consistent with experiments [32] in which region of high branch point
density coincided with regions of smaller fiber diameters. The areas with high fiber mass
are formed from fibrin production rates were low and have thick fibers and small pores. For
some parameters, including the branch point formation rate kb, we do not have estimates
from the literature. Other parameters, e.g., the rate of thrombin production α or the plasma
concentration of fibrinogen fup, will naturally vary. We next look at how variation in kb, α
and fup affects fibrin gel formation.
3.1.1 Thrombin Production Rate
The thrombin production rate α is an element in the Michaelis-Menten rate that medi-
ates thrombin flux at the injury zone. When the prothrombin concentration is high (i.e.,
close to zup), the flux of thrombin is approximately α. This is the scenario at the beginning
of a simulation. As prothrombin becomes depleted, the flux of thrombin asymptotes to αβ z2.
With larger values of α, prothrombin near the wall is depleted faster. The balance between
depletion and diffusion is the essential concern.
We look at varying α over two orders of magnitude. A reasonable hypothesis is that a
larger α would yield a faster growing clot and higher thrombin concentration. Also, from




















Figure 3.3: Clotting time distribution without flow. It is shown in seconds. The injury





















































































































































































































































































































































































































































Figure 3.5: Pore size and fiber diameter without flow in (nm).α = 10−5 cm µM/s, kb =
10µM−2s−1, fup = 10µM
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will result in higher branch point density and thinner fibers in clots as compared to a lower
thrombin concentration.
Initially, larger α does produce more thrombin. However, once the prothrombin near
the wall is depleted, the conversion of prothrombin to thrombin becomes limited by the
rate that prothrombin diffuses to the wall. Figure 3.6 shows the maximum and average
thrombin concentration over the entire domain verses time.
All of the maximum concentrations occur at the wall. The sharp peak occurs when
prothrombin that started near the wall is depleted. For later times, there is a higher
maximum and average concentration of thrombin for smaller α. The maximum of the
thrombin concentration over time and x1 increases with α but decreases as one moves away
from the wall.
Higher thrombin concentration does result in a higher branch point density. As shown
in Figure 3.7, near the wall, there is a high branch point density for all values of α, and
this near wall density also increases with α. Away from the wall the branch point density is
similar for the various α’s. Clotting also occurs sooner near the wall for larger values of α
due to the high thrombin concentration that results. However, away from the wall clotting
occurs at about the same time for different values of α (Figure 3.8). This is explained by
the limited variations in thrombin concentration across α’s away from the wall. Overall,
the fibrin mass density distributions shown in Figure 3.9 vary little or the different α’s,
with the greatest difference being a somewhat larger area of maximal fiber density above
the injury site.
Interestingly, the fibrin mass density is approximately uniform while the branch point
density varies for different values of α. Fibrinogen is depleted near the injury zone and is
only supplied through diffusion. The Damko¨hler number is greater than one for all values
of α investigated, implying that the rate of depletion is faster than the rate of transport.
In fact, the Damko¨hler number is greater than one for all reaction-diffusion processes in
this system. Because the rate of diffusive transport is slow, the same amount of fibrinogen
becomes fibrin and becomes incorporated in the gel.
Because the rate of thrombin production (and consequently fibrin monomer production)
yields different branch point densities for different values of α but similar fibrin mass
densities, the pore size and the fiber diameter vary with α. The central core of the clot is
more significantly affected than other regions. As shown in Figure 3.10, for large α, the
clot is composed of a core of thin, tightly packed fibers, an inner shell of thick fibers, and
an outer shell of medium diameter, loosely packed fibers. For small α, the clot has a larger
27
Time (s)



































Figure 3.6: Thrombin concentration over time without flow. Left: Maximum and average
thrombin concentration over the entire domain as a function of time. Right: Maximum and
average thrombin concentration over x1 and t as a function of x2. The dashed curves repre-
sent average concentrations, the solid curves represent maximum concentrations. The blue,






































































































































































































































































































Figure 3.8: Cotting time for different α without flow. This is shown for each spatial
location in seconds. Top: α = 10−6cmµMs−1. Middle: α = 10−5cmµMs−1. Bottom:





















































Fibrin Mass Density in Gel
Figure 3.9: Fibrin mass density plotted for different α without flow. This is shown for each
spatial location in µM at t = 300s. Top: α = 10−6cmµMs−1. Middle α = 10−5cmµMs−1.


















































































 Pore Size and Fiber Diameter
Figure 3.10: Clot structural properties plotted for different α without flow. The pore size
(left) and fiber diameter (right) for in nm at t = 300s. Top: α = 10−6cmµMs−1. Middle:
α = 10−5cmµMs−1. Bottom: α = 10−4cmµMs−1. kb = 1µM−2s−1. fup = 10µM
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core of thicker fibers with medium pore sizes and an outer shell that consists of medium
diameter fibers and has large pores.
The parameter α affects the rate of thrombin production, but the conversion of pro-
thrombin to thrombin is limited by the rates of diffusion of prothrombin and thrombin. As
a result, varying α over several orders of magnitude does not change the spatial extent of
the resultant gel. The branch point density and fiber diameter near the wall do change
because changes in α affect the rate of fibrin monomer production.
3.1.2 Rate of Branch Point Formation
In the model, there are two rate constants that control fibrin polymerization, kl and kb.
While there are several estimates for kl ([15], [39], [24]), there is very little known about
the rate, kb. We explore the effect that varying kb has on the clot structure.
We find that the value of kb significantly affects clotting time. This is consistent with
results from Ziff’s gelation model [42]. The Ziff model consists of a condensation system
that occurs between monomers. Each monomer contains f number of binding sites or
functional sites for other monomers to bind. As Ziff shows, in order for gelation to occur
in a condensation system, there must be more than two functional sites on each monomer.
Furthermore, the gel time decreases as the number of functional sites increases. For the
model described in Chapter 2, there are two types of reactions, linear extension and branch
point formation. The effective number of functional sites for linear extensions is two and
for branch point formation is three. This means that it is essential to have branch point
formation for gelation to occur. The value of kb (relative to that of kl) influences the effective
number of functional sites in the fibrin oligomers. For all of the simulations described below,
kl is kept constant. The rate constant, kb is described in terms of the baseline value ko,
where ko = 10µM
−2s−2.
Table 3.1 shows the time for the first appearance of a gel, as well as the maximum
gel width and the maximum gel height at t = 300 s. The first appearance of a gel occurs
sooner with increasing kb. The parameter kb also has some effect on how clot size changes
with t. Smaller kb values produce more slowly growing clots than higher ones do. It is
unclear what the size of the clot will be at steady state. Due to computational limitations,
this is not explored.
It is important to note that branch point formation and linear reactions are in
competition with each other for monomers. The last column in Table 3.1 shows the mean
number of monomers per branch point in the gel at t = 300 s. This ratio shows that linear
33
Table 3.1: Gel time and clot size for various branching rates. Here t = 300 s. ko =
10µM−2s−1, α = 10−4cmµMs−1, fup = 10µM
kb First Gel Time Max Gel Width Max Gel Height Monomer/Branch Point
ko/10 58 s 190µm 42µm 674.4
ko/5 30 s 212µm 45µm 421.9
ko/2 15 s 221µm 48µm 210.7
ko 10 s 228µm 52µm 128.1
2ko 8 s 228µm 52µm 79.3
reactions are favored over branch reactions in the gel but that increasing kb decreases the
number of monomers per branch point.
To better quantify the competition, we look at the rate of branch point formation and
linear extension. The overall branch point formation rate is kb6
(
R3 − (3RsR2g +R3g)
)
and




. Figure 3.11 shows that the competition
between extension reactions and branch point formation is not significantly affected by kb
over the range of values considered. There is at most a 10% difference between the maximum
and average rate of extension reaction for kb = ko/10 and kb = 2ko. Of course, the average
and maximum overall rates of branch point formation are more significantly affected by kb.
The peak in the overall branching reaction rate corresponds to the higher fibrin source rate
near the wall. The subsequent decrease is due to a decrease in the rate of production of
monomer from the reaction between fibrinogen and thrombin becoming diffusion limited.
Figure 3.12 shows the branch point concentration at t = 300 s. As kb is increased, the branch
point densities increase and also show greater variation across the clot. The mass of fibrin
in the gel also changes when the rate of branch point formation changes. However, these
changes are limited due to the similarities in the overall rate of linear extension reactions
for the different kb values and the dominance of the linear extension reactions over the
branching ones. Figure 3.13 shows the distribution of fibrin mass density in the gel. They
are similar and show similar amounts of spatial variably, except for the smallest value,
kb = ko/10. At this rate constant, the fibrin mass in the gel is more uniform.
The combination of branch point and fibrin mass density leads to different pore size
and fiber diameter, as shown in Figure 3.14. For the rate constant, kb = ko/2, the fiber
diameter is large and has low variability across the clot. As kb increases, the clot becomes
more uniform and denser with smaller fiber diameters and pores. As kb decreases, for ko/2
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Figure 3.11: Branch and linear reaction rates plot for different kb without flow. This is
shown for kb = ko/10, ko/5, ko/2, ko, 2ko with ko = 10µM


































































 Branch Point Density in Gel
Figure 3.12: Branch point density distribution plotted for different kb without flow. This
is shown for branch point density in gel for four rates of kb. ko = 10µM
−2s−1, α =























































 Fibrin Mass in Gel
kb = 2ko
x1(µm)












Figure 3.13: Fibrin mass density plotted for different kb without flow. This is shown for
fibrin mass density in gel for four values of kb. ko = 10µM












































































































































































































































































































































































































there is more spatial variation in the pore sizes as well as larger values of the maximum
pore size and maximum fiber diameter.
3.1.3 Upstream Fibrinogen Concentration
There are three types of fibrinogen disorders: afibrinogenemia, hypofibrinogenemia, and
dysfibrinogenemia. People with dysfibrinogenemia have normal concentrations of fibrinogen
but their fibrinogen contains structural abnormalities. People with afibrinogenemia and hy-
pofibrinogenemia have lower than normal fibrinogen concentrations. According to Acharya
and Dimichele (2008), afibrinogenemia patients have< 0.59µmol/L of fibrinogen circulating
in the blood. Hypofibrinogenemia patients typically have between 0.59 − 2.4µmol/L.
Normal fibrinogen concentrations in human blood fall in the range 5.9− 11.8µmol/L. All
of these disorders cause clotting issues. Hypofibrinogenemia and dysfibrinogenemia cause
prolonged clotting times. Patients with afibrinogenemia are said to not clot. [1]
The model from Chapter 2 can be modified to study afibrinogenemia and hypofib-
rinogenemia by altering the upstream fibrinogen concentration. We look at fibrinogen
concentrations of 0.5, 1, 5, 10, and 50µmol/L. Table 3.2 shows the time a gel first appears
for each of these cases. For low upstream fibrinogen concentration (fup = 0.5− 1µmol/L),
no clot appears by 2000 s. It takes more than eight times as long for a fibrin gel to
appear for fup = 5µmol/L than for fup = 10µmol/L. Increasing the upstream fibrinogen
concentration by another factor of five (fup = 10µmol/L to fup = 50µmol/L), it is six
times faster. Figure 3.15 shows the growth rate of the gel is affected by the fibrinogen
concentration. Figure 3.16 shows the branch point density of fibrin gels for various upstream
fibrinogen concentrations. With low fibrinogen concentration no gel is able to form. With
high upstream fibrinogen concentration, there is a larger branch point density along the
lower vessel wall. While the branch point density is higher in larger upstream fibrinogen
concentration, the profile shape is consistent with normal upstream fibrinogen concentra-
tion. The fibrin mass density shows a similar effect and is shown in Figure 3.17.
Table 3.2: Gel time and clot size various fup. kb = 1µM
−2s−1, α = 10−4cmµMs−1





















Figure 3.15: The height and width of gels formed with different fibrinogen concentrations:
fup = .5fo = 5µmol/L (black), f
up = fo = 10µmol/L, (red) and for f
up = 5fo = 50µmol/L,
(blue). kb = 1µM
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 Branch Point Density
Figure 3.16: Branch point density for various upstream fibrinogen concentrations fup =
fo/10 = 1µmol/L, f
up = fo/2 = 5µmol/L, f
up = fo = 10µmol/L,and for f
up = 5fo =
50µmol/L. The left side of the graph shows the density for branch point densities in the sol
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Figure 3.17: Fibrin mass density for various upstream fibrinogen concentrations fup =
fo/10 = 1µmol/L, f
up = fo/2 = 5µmol/L, f
up = fo = 10µmol/L,and for f
up = 5fo =
50µmol/L. The left side of the graph shows the density for fibrin mass densities in the sol




As expected, the larger branch point density and fibrin mass density seen in high
upstream fibrinogen concentrations results in fibrin fibers having a smaller diameter (Figure
3.18) and a smaller pore size (Figure 3.19).
3.2 Flow
Next, we explore the model in flow. Fluid flow moves coagulation proteins and oligomers
away from the injury site, while suppling fibrinogen and prothrombin. The obvious question
is what is the overall effect of the fluid flow on fibrin clot formation?
We begin by prescribing a parabolic flow at the left boundary with a wall shear rate
of 10 s−1. A low shear rate is representative of shear rates in veins or other smaller blood
vessels. We use a domain twice the size as before (Lx1 = 800µm and Lx2 = 200µm). Fibrin
takes time to form gel from a collection of oligomers. Without flow and for α = 10−6µM s−1
and kb = 10µM
−2 cms−1, it takes 58 seconds for fibrinogen to become a fibrin gel. At a
wall shear rate of 10 s−1, an oligomer 1.5µm from the wall would travel 900 µm in 58 s
(assuming a shear flow near the wall). This suggests gelation cannot be initiated over an
injury zone by the action of thrombin produced there.
The model also produces this result. Fibrin monomer is produced only in a thin strip.
One part of the strip is over the injury zone near where thrombin is produced. Thrombin
and fibrinogen advect downstream with the fluid and interact to produce fibrin monomer
away from the injury zone. The fibrin continues to polymerize while moving downstream
and a small amount of gel is produced along the bottom wall first at a location around
x1 = 725µm. The gel then slows the fluid velocity around it which allows additional gel to
form on the upstream side of the clot. Figure 3.20 shows the branch point density in the gel
and the fibrin source rate at t = 150s. Note in these simulations we set kb = kl = 0 near
the right wall to prevent nonphysical accumulations along the bottom corner. The bottom
plot shows the shear rate. As the gel forms, the fluid slows in the presence of the gel (due
to the Brinkman term in the Navier Stokes equations).
While it is possible for the clot to grow upstream, it is not physiological for a fibrin clot
to be initiated downstream from an injury. This is consistent with experimental data from
the Neeves Lab [30] where they find fibrin clots do not form on a flat surface. We look
at physiological conditions to see what is different between our model and the situation
in the body. One difference is, in physiological conditions, platelets bind prior to fibrin
clot formation. A collection of platelets could hinder the flow over the injury zone and
initiate the conversion of prothrombin to thrombin on platelet surfaces away from the wall.
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Figure 3.18: Fiber diameter for various upstream fibrinogen concentrations. Here fup =
fo/10 = 1µmol/L, f
up = fo/2 = 5µmol/L, f
up = fo = 10µmol/L,and for f
up = 5fo =
50µmol/L at t =150 s kb = 1µM
−2s−1, α = 10−4cmµMs−1.
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Figure 3.19: Pore size for various upstream fibrinogen concentrations. Here fup = fo/10 =
1µmol/L, fup = fo/2 = 5µmol/L, f
up = fo = 10µmol/L,and for f
up = 5fo = 50µmol/L at
t =150 s kb = 1µM
−2s−1, α = 10−4cmµMs−1.
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Figure 3.20: Source rate, branch point density, and shear rate for unhindered flow. Top:
Source rate distribution µMs−1. Middle: Distribution of branch point density in the gel
in µM . Bottom: Shear rate of the fluid in s−1 at t = 150 s, given α = 10−6µM s−1,
kb = 10µM
−2 cms−1, and fup = 10µM .
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First, we explore fibrin formation in hindered flow. In Chapter 4, we look at prothrombin
conversion away from the wall.
3.3 Hindered Flow
In order to simulate a group of platelets or any other cells bound upstream from the
injury zone, we include a “bump” or an area with a large Brinkman coefficient (α1) in the
domain. We do this for an area about 9µm tall and 20µm wide near the upstream end
of the injury site. This addition, shown in Figure 3.21, diverts fluid around the bump and
slows fluid flow in and downstream of it. As we show, this allows fibrin gelation to occur
over the injury site.
For the following simulation, we use the original domain (Lx1 = 400µm and Lx2 =
100µm) and a shear rate of 100 s−1. As in the previous simulation, we set kb = kl = 0 near
the right boundary. Figure 3.22 shows thrombin concentration, fibrinogen concentration,
and fibrin source rate. The yellow curve on each plot shows the 25% maximum contour for
the Brinkman coefficient and the red numbers still delimit the injury zone. The bump allows
thrombin and fibrinogen to diffuse upstream and stay around the injury site for a longer
period of time. There is depletion of fibrinogen in the areas with small velocities but overall
the constant supplying of fibrinogen and prothrombin around the injury zone leads to an
increase in fibrin monomer production compared to the no flow cases. Figure 3.23 shows
the branch point density and fibrin mass in the gel. Notice that the highest concentration
for both occurs on the downstream side of the gel where the source is highest. Also, notice
the concentration of fibrin mass and the branch point density in the gel are significantly
higher than in the no flow case (shown in Figure 3.12 and 3.13). When the simulation runs
longer, a gel grows along the bottom wall but does not grow much taller than the bump.
Figure 3.24 shows that the gel has a small variation in fiber diameter with a wide range
of pore sizes. The upstream edge of the gel has large pores while the downstream side of
the clot has small pores. Notice, that gels formed in flow do not have the same core, inner
shell, outer shell structure that was seen in the no flow case. Fiber diameters are much
more uniform. There is a small outer region where the fiber diameters are small and the
pores are very large. As in the no flow case, the gel begins at the wall and grows outward
into the lumen and along the walls.
For the remainder of this chapter, we use the following parameter values unless otherwise



























Figure 3.21: Brinkman coefficient distribution for hindered flow. The top plot shows the
value of α1, the Brinkman coefficient. The value α1 is large in the area upstream from the
injury zone to slow down the flow. The fluid velocity vectors are also shown on the plot.
The bottom plot is zoomed in on the bump.
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Figure 3.22: Coagulation proteins and source rate distributions in flow. Top: Thrombin
concentration in µM ,. Middle: Fibrinogen concentration in µM . Bottom: Fibrin source
rate for a gel made at α = 10−5 cmµM/s, kb = 1µM−2s−1,fup = 10µM , and γ = 100 at
t = 130 s
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Figure 3.23: Branch point and fibrin mass density distributions in flow. Top: Branch
point density in gel µM . Bottom: Fibrin mass density in gel in µM for a gel made at
α = 10−5 cmµM/s, kb = 1µM−2s−1,fup = 10µM , and γ = 100 at t = 130 s
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Figure 3.24: Clot structural properties in flow. Top: Fiber diameter (nm). Mid-
dle: Pore size (nm). Bottom: Clot time(s) for a gel made at α = 10−5 cmµM/s,
kb = 1µM
−2s−1,fup = 10µM , and γ = 100 at t = 130 s.
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3.3.1 Shear Rate
Next, we explore how the wall shear rate affects fibrin gelation. To begin with, the
shear rate affects the profile of the fibrin monomer source. Figure 3.25 shows the source
rate for four different shear rates at t = 115s. For small shear rates (1 s−1 and 10 s−1), the
highest source rate occurs away from the wall while for high shear rates, the highest source
rates occur at the wall and the source rates are generally higher for larger sheer rates for
the range considered. The bump upstream from the injury zone slows the flow and lowers
the Pe´clet number, creating a region in which transport is diffusion domination even for
the highest shear rate considered. For low shear rates, this region extends to the end of
the injury zone and allows proteins to diffuse effectively over a larger area. For high shear
rates, this region ends around 200 µm (where the highest source rate occurs). Inside of
these regions, fibrinogen is converted to fibrin faster than diffusion can replenish it and so
fibrinogen becomes depleted. Figure 3.25 also shows the fibrin mass density in the gel. The
low, diffused source rate created in the low shear environment leads to gels that spread
downstream and have low branch point and fibrin mass densities.
For high shear rates, the fibrin is dense and is contained mostly within the region
where the Pe´clet number is low. After an initial transient, the source rate distribution
remains qualitatively the same as time advances and fibrin continues to accumulate on the
downstream edge of the clot. The continued growth of the fibrin density at this location
brings up issues for the fibrin volume fraction. As described so far, the model does not limit
accumulation of fibrin mass. Here, the high shear rates case exhibits volume fraction near
20%. In Chapter 5, we present a model with more realistic dynamics that can restrict the
gel volume fraction due to hindered transport in the presence of the gel.
Figure 3.26 shows the pore size and fiber diameter of gels that result for the different
shear rates. Clots formed at low shear rates have larger pores than those formed at higher
shear rates. The fiber diameters vary, with the thickest fibers occurring just inside the
upstream edge of the clots. The high shear environment creates dense gels that are located
in the diffusion dominated regions. These gels have a core with small pores and nearly
uniform fiber diameters. Notice that with high shear, the fibrin clots do not completely
cover the injury zone. To do so, a larger region of reduced flow is needed. This is not a
surprising result. Physiologically, clots formed at higher shear rates have less fibrin than
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Figure 3.26: Clot structural properties plotted for different γ in flow. Left: Pore size
(nm). Right: Fiber diameter (nm). Top to Bottom: γ = 1 s−1, γ = 10 s−1, γ = 100 s−1,
γ = 250 s−1. At t = 115 s. α = 10−5 cmµM/s, kb = 1µM−2s−1, and fup = 10µM .
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3.3.2 Thrombin Production Rate
When the fluid velocity is zero, the conversion of prothrombin to thrombin is limited by
the diffusivity of prothrombin. Here, we explore how thrombin production is affected by
the fluid velocity and the continual supply of prothrombin from upstream. Note that the
bump creates a region in which the fluid velocity is sufficiently slow that diffusion is the
essential transport process.
When the simulation starts, zup = 1 and the flux of thrombin from the injury is
approximently α. For large α, prothrombin is depleted quickly from the region just above
the injury and the flux rate becomes limited by the rate at which prothrombin diffuses
to wall from outside the depleted area. Unlike in the zero fluid velocity case with flow,
prothrombin advects with the fluid, and the distance that prothrombin must diffuse to
the injury zone is limited. For medium values of α, the depletion of prothrombin takes
longer; however, once depleted, prothrombin exhibits the same behavior and has the same
concentration profile as for the large α case. For small values of α, it takes even longer for
prothrombin to become depleted; however, again it eventually yields the same source rate
distribution as for large values of α. The source rate distributions for three values of α are
shown in Figure 3.27. Early on, each value of α has a distinct source rate distribution.
By t = 143 s the source rate distributions are similar for the two higher values of α. By
t = 285 s, the source rate distributions are even more similar for all three values of α, but
the highest source rate in the low α case is found in a more restrictive region. This indicates
that for this α, production of thrombin is both transport and reaction limited.
Because the source rates become similar for all values of α, they yield similar branch
point density and fibrin mass density distributions. The pore size and fiber diameter for all
three α’s are shown in Figure 3.28. A smaller value of α yields a larger area with thicker
fibers. This is consistent with experimental results that clots made with more thrombin
have smaller fibers than clots formed with less thrombin.
3.3.3 Upstream Fibrinogen Concentration
Similar to the no flow case, if the upstream fibrinogen concentration is too low, no gel
forms. Figure 3.29 shows the size of the gel for two upstream fibrinogen concentrations,
fup = fo = 10µM and f
up = fo/2 = 5µM . For the low fibrinogen concentrations it takes
more than twice as long for the gel to first appear. Unlike the no flow case, the continual
supply of fibrinogen allows the gel to grow to the size of one formed with the normal






































































































































































































































































































































































































Figure 3.28: Clot structural properties plotted for different α in flow. Left: Pore size
in (nm). Right: Fiber diameter in (nm). Top to Bottom: α = 10−6 cmµM/s,α =
10−5 cmµM/s, α = 10−4 cmµM/s. At t = 285 s.
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Clot Width (solid) and Clot Height (dashed)
fup = fo/2
fup = fo
Figure 3.29: Clot structural properties plotted for different fup in flow. The clot
dimensions for fup = 10µM (red) and fup = 5µM (blue). γ = 10 s−1, α = 10−5 cmµM/s,
and kb = 1µM
−2s−1.
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gel height plateaus around the same value for both fibrinogen concentrations. The fibers
continue to thicken after the clot has plateaued. While the resulting clots have similar
spatial extents, the fibers in them have different diameters. Figure 3.30 shows the pore
size and fiber diameter for three gels. The first is a gel created with normal fibrinogen
concentration at t = 187 s, the second is a gel formed with low fibrinogen concentrations at
t = 187 s, and the third is a gel formed in with low fibrinogen concentrations at t = 415 s.
With higher fibrinogen concentration, gels have larger regions where the pores are small.
3.3.4 Rate of Branch Point Formation
The rate constant for branch point formation, kb, affects not only the concentration of
branches but also the gel growth rate. As a reminder to the reader, the overall branch
point formation rate is kb6
(
R3 − (3RsR2g +R3g)
)





. Unlike the situation for fibrin gels formed without flow (Figure 3.11),
increasing kb in the case of flow causes an increase in branch formation and a significant
decrease in the rate of linear reactions. Figure 3.31 shows that for all kb considered, the
rate of linear reactions is higher than the rate of branch point formation. Increasing kb
by a factor of 10 from ko/10 to ko causes a 42% reduction in the maximum rate of linear
reactions for all time and increases the rate of branch point formation by a factor of 5.
With flow, it appears that the two types of reactions compete strongly with one another.
This is different from what is seen in simulation without flow, where changes in kb did not
greatly change the rate of linear reactions. This difference could be due to the changes in
the source rate distribution. With flow, the source rate is substantially higher in a small
region on the downstream end of the injury zone. Without flow, the source rate is positive
over a larger area but its maximum is much smaller than that in flow.
Table 3.3 shows the first time that a gel appears anywhere, the spatial average number
of monomers per branch point, and the spatial average gel branch point density at t = 45 s.
For kb = ko/10, clots have many fewer branch points. As in the zero velocity case, increasing
kb causes the clot to be initiated sooner. This is also shown in Figure 3.32. Gels formed
with larger kb not only have higher branch point densities but are larger in area at any
given time. We see that this model has diffusion limited behavior.
We are unable to answer the questions, will the gels converge to the same size and if
they converge, does it happen within a physiologically relevant time frame? The simulations
do reveal that for different values of kb, gels contain different size fibers and pores shown
in Figure 3.33. Fiber diameters increase when kb decreases. For large kb, pore sizes and
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Figure 3.30: Clot size plotted for different fup in flow. Top: Pore size in nm. Bottom:
Fiber diameter in nm. Left: fup = 10µM at t = 187 s, Middle: fup = 5µM at t = 187 s,
Right: fup = 5µM at t = 415 s. γ = 10 s−1, α = 10−5 cmµM/s, and kb = 1µM−2s−1.
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Figure 3.31: Rate of branch and linear reactions plot for different kb. Top, left: Average
rate of branch point formation. Top, Right: Linear reaction. Bottom, Left: Maximum rate
of branch point formation. Bottom, Right: Linear reaction. For kb = ko/10, kb = ko/2,
kb = ko, and kb = 2ko. γ = 10 s



















































































































































































































































































Figure 3.32: Branch point and fibrin mass density plotted for different kb in flow. Left:
Branch point density. (µM) Right: Fibrin mass density (µM). From top to bottom:
kb = ko/10, kb = ko/2, kb = ko, and kb = 2ko at t = 45 s. γ = 10 s
−1, α = 10−5 cmµM/s,
ko = 10µM
−2s−1, and fup = 10µM
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Figure 3.33: Clot structural properties, plotted for different kb in flow. Left: Pore size
(nm) Right: Fiber diameter (nm). From top to bottom: kb = ko/10, kb = ko/2, kb = ko, and
kb = 2ko at t = 45 s. γ = 10 s
−1, α = 10−5 cmµM/s, ko = 10µM−2s−1, and fup = 10µM
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diameter distribution show a clot filled with thin tightly packed fibers. As kb decreases,
fiber diameters and pore sizes become larger.
3.4 Limitations and Extensions
While this model creates a fibrin gel and gives a two-dimensional distribution of fiber
diameter and pore size, the model does not explicitly model protofibril formation followed
by lateral aggregation. Lateral aggregation is an important step in the thickening of fibers.
The model currently uses a geometric argument that distributes the fibrin at a location
evenly among branch points and uses this and the distance between branch points, i.e.,
(1/Bg)
1/3, to calculate fiber diameter (see Appendix A for details). This simplification
does not allow for a distribution of fiber sizes at a single location. Also, it has been seen
experimentally that fibers align with the fluid velocity, at least for sufficiently fast flows.
Some experimentalists have seen thick fibers oriented in the direction of flow and with short
thin fibers connecting them ([13], [5]). In order to model this type of behavior, the model
would have account for fiber orientation and include fiber stresses and elasticity.
Currently, the model allows fibrin to accumulate in a single location without any lim-
itation on the gel density there. This can lead to the volume fraction of fibrin becoming
greater than one. At low volume fractions, proteins are able to diffuse through the fibrin
gel as if it were plasma. When real fibrin accumulates, real proteins (especially large fibrin
oligomers), should diffuse with a smaller diffusivity. Similarly, as the volume fraction of gel
increases, so does the drag on proteins as they move through the gel. In Chapter 5, we
modify the model to include some of the effects that gel has on transport while maintaining
our current model framework. More extensive models, such as a 2-phase fluid model which
treats fibrin gel as a fluid, might more accurately model this behavior.
CHAPTER 4
ALTERNATIVE MODEL FOR THROMBIN
PRODUCTION
As shown in Chapter 3, there must be a region protected from flow for a fibrin gel to
form over an injury zone. Platelets and other cells could provide such a barrier. Platelets
collect on an injury site and provide a surface for the conversion of prothrombin to thrombin.
In order to approximate thrombin production on platelets, not the vessel wall, we model
prothrombin conversion in the fluid in and around porous beads.
4.1 Model
At the current resolution, we cannot model individual platelets. We instead model a
platelet aggregate’s contribution to thrombin production using a prescribed distribution of
prothrombinase, that is located where a high Brinkman coefficient is prescribed to mimic
the platelet thrombus’ ability to hinder the flow. The aggregates are located over the injury
zone, (L1 < x1 < L2).
This model contains four coagulation chemicals: prothrombin in the fluid, Z2; bound
prothrombin, Zb; thrombin, E2; and fibrinogen, F . Prothrombin in the fluid binds to
prothrombinase complex Pr on platelet surfaces. The concentration of the Pr complexes
is specified in each simulation. Bound prothrombin can unbind or it can be cleaved by
prothrombinase to become thrombin. As before, thrombin cleaves fibrinogen into fibrin
monomer. Let z2, zb, e2, and f denote the concentration of prothrombin, bound prothrom-




+∇ · (uz2) = ∇ · (Dz∇z2)− kon(pr − zb)z2 + koffzb, (4.1)
∂zb
∂t
= kon(pr − zb)z2 − koffzb − kcatzb, (4.2)
∂e2
∂t
+∇ · (ue2) = ∇ · (Dz∇e2)− kate2 + kcatzb, (4.3)
∂f
∂t




Here, kon is the binding rate of prothrombin to prothrombinase, koff is the unbinding rate,
and kcat is rate prothrombin is cleaved to thrombin. The parameter, pr, is described below.
Notice in Equation 4.2 that bound prothrombin does not advect or diffuse; thus the equation
is effectively an ODE at each point in the domain. Along the top and bottom wall, the
variables z2, e2, and f have no flux boundary conditions. The left and right boundaries are
the same as those described in Chapter 2. All other parameters serve the same role as in
the previous model. The equations for W , R, V , θ, and B are unchanged.
Because prothrombin actually binds first to a platelet’s surface and then to prothrom-
binase, the number of prothrombin molecules bound to a platelet is limited to the smaller
of the number of prothrombin receptors and the number of prothrombinase complexes. In
general, the number of prothrombin receptors is the lower one and we use it to estimate the
values of pr.
It is estimated that platelets express 2000 prothrombin receptors on their membranes,
or 26 fmol/cm2 [4]. In the model, pr is a volume concentration. We convert 26 fmol/cm
2
to a volume concentration by dividing by the average platelet aggregate height, 5.6µm, to
get ≈ 46nM . We set the maximum receptor concentration, max(pr) ≡ Ro = 50nM . We
simulate three pr distributions, shown in Figure 4.1. The shape of the pr distribution and














































Here Lmid is the horizontal center of the aggregate and A describes the width of each
aggregate and is selected to be 0.2133.
The initial Brinkmann coefficient is co-localized with each of the pr distributions and
is physiologically similar to those for platelet aggregates. The first distribution represents
two aggregates that overlap; the centers of the aggregates are located at x1 = 186µm
and x1 = 214µm. The second distribution represents two aggregates whose centers are
separated by 57µm. The centers of these aggregates are located at x1 = 173µm and
x1 = 230µm. The third distribution represents two aggregates whose centers are separated
by 103µm. The centers of these aggregates are located at x1 = 148µm and x1 = 251µm.






































Figure 4.1: Prothrombinase/Factor II distributions. Three types of concentration distri-
butions for pr in nM. The white arrow indicates the relative magnitude and velocity of the
fluid. The Brinkman coefficient distributions have the same form.
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4.2 Results
We look at events in a blood vessel segment of length 400µm and height 100µm. For
all the results described below, the wall shear rate is γ = 10 s−1 and the branching rate is
kb = 10
−6 µMs−1. All other parameter values are listed in Appendix B.
There are several important differences between this model and the model described in
Chapter 2. First, prothrombin is converted to thrombin in a portion of the fluid instead of
on the wall. Second, the Brinkman coefficient is highest in the regions where thrombin is
produced. For each of the pr distributions, the fluid moves slowly in the region over the
injury. This yields a Peclet number less than 1, which indicates that, in the region, diffusion
is the dominant form of transport. Consequently, fibrin monomer production acts similarly
to the zero velocity case described in Chapter 3.
Initially, thrombin and fibrin are produced over the entire region where prothrombinase
is located (instead of only along the bottom wall). Then prothrombin and fibrinogen become
depleted in the interior of the region. Although prothrombin and fibrinogen advect into the
domain with the fluid, the nature of the velocity field near the platelet aggregates causes
the proteins to move mostly up and around the platelet aggregates. Hence, fibrinogen is
then converted to fibrin on the edge of the protected region giving rise to the distributions
seen in the first row of Figure 4.2. Because the fibrinogen and prothrombin advect with
the fluid, the upstream side of the platelet aggregates sees a higher source rate yielding a
higher branch point density and a higher fibrin mass density.
The different pr and Brinkman coefficient distributions result in different fluid profiles.
The horizontal and vertical velocity profiles are shown in Figure 4.3. In the simulations using
any of the three pr and Brinkmann coefficient distributions, the vertical fluid component
shows that the fluid flows toward the center of the vessel on the upstream side of the
platelet aggregates and toward the vessel wall on the downstream side of the aggregates.
The distance between the two aggregates affects the fluid profiles. In the simulation using
the type 1 distribution, the two platelet aggregates act as a single aggregate. In the
simulation using the type 3 distribution, the fluid flows between the platelet aggregates.
In the simulation using the type 2 distribution, the fluid velocity between the platelet
aggregates is slower compared to the type 3 distribution.
While all three types of pr and Brinkman coefficient distributions represent the same
number of platelets, the total fibrin density in each is different. Because type 3 has a
larger region protected from flow and it has significant fluid flow between the platelet
































































































































































































































































































































































































































































































































































































































































































































































density (3.97×104µM), followed by type 2 (3.45×104µM), then by type 1 (2.87×104µM)
at 250 seconds. Here the total fibrin density is defined as the sum of the fibrin mass density
over the whole domain. This is also verified by looking at the difference between the source
rate of fibrin over the whole domain and the rate that fibrin mass density in the sol leaves














Here u is the horizontal fluid velocity at x1 = 400µm, the right edge of the domain. The
function r(t) describes the total amount of fibrin that is in the domain at time, t and is
shown in Figure 4.4. For all time after seven seconds, type 3 has the most fibrin in the
domain, followed by the type 2, then type 1.
Figure 4.5 shows the pore size, fiber diameter, and clotting time for each pr and
Brinkmann coefficient distribution type. From the clotting times, we see that most of
each clot forms within the first 30 s. The median clotting times for Type 1, 2, and 3 are
21s, 20s, and 26.5s, respectively. For all three types, fiber diameters range from 100-300
nm. The fiber diameters are smallest near the horizontal center of the aggregates. The
fibers on the outside of the platelet aggregate continue to thicken over time and therefore
have a larger fiber diameter.
4.3 Conclusion
From the alternative model for thrombin production, we are able to see the effects that
platelet aggregates have on fibrin clot formation and structure. Although the model did
not include individual platelets, it did include the impact that platelet aggregates have
on flow with the use of a Brinkman term. The flow around the platelet aggregates is
slowed and allows enough of a protected area for fibrin fibers to form. The concentration
of prothrombinase located in the same spacial positions as the large Brinkman term allows
for thrombin to be produced in a larger area (not just at the vessel wall) which affects the
fibers as well as the time the clot formation. The size and position of the platelet aggregates
affects the structure properties of the fibrin clots that form.
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Because fibrin gel, even with volume fraction less than 0.1, affects the diffusion coefficient
of protein [41] and proteins moving through a gel (especially with high volume fraction)
experience drag, we seek to create a model that includes effects of volume fraction exclusion
without explicitly including a full two-state fluid/gel model. In order to derive the correct
modifications, we follow Leiderman and Fogelson 2013 [21] and unpublished notes by Fo-
gelson [9].
These changes also address a limitation of the model described in Chapter 2. That
model does not contain any mechanisms that restrict the amount of fiber gel that can be
present at each specific location. In fact, the volume fraction of gel can become greater
than one. Clearly, this is not physiological. In this chapter we modify the model to include
terms that hinder the advection and diffusion of coagulation proteins and oligomers in the
presence of higher volume fraction of gel. By restricting the movement of molecules in the
solvent, we limit gel accumulation.
5.1 Derivation
We begin by looking at a three species system of free protein, gel and fluid. Let
(θpr,upr), (θg,ug), and (θf ,uf ) be the volume fraction and velocities of protein, gel, and
fluid, respectively. The sum of the volume fractions must be one. The force balance equation
for protein is
0 = ξpr,fθprθf (uf − upr) + ξpr,gθprθg(ug − upr)− θpr 5 µpr. (5.1)
Here, ξpr,f is the drag coefficient between fluid and protein, ξpr,g is the drag coefficient
between the gel and protein, and µpr is the protein chemical potential. Typically, µpr =
kBT log cpr, where cpr is the concentration of protein, kB is the Boltzmann constant, and
T is the temperature in Kelvin. The concentration of a protein is defined as the amount
per total volume. However, we are interested in a system where any given volume can
be occupied by both fluid and gel. Since proteins reside only in the solvent, the effective
concentration of protein is defined as the amount per solvent volume, c˜pr = cpr/θf . Let
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µpr = kBT log c˜pr which is a reasonable choice if the protein is dilute. Assuming that the
gel is stationary, ug = 0, and proteins are dilute, θpr << 1, we can solve (5.1) for upr,
upr =
ξpr,f (1− θg)
ξpr,f + (ξpr,g − ξpr,f )θguf −
1




Define r to be the ratio of the drag coefficients, r = ξpr,g/ξpr,f , and define the unhindered




1 + (r − 1)θguf −
1




Applying the quotient rule for derivatives, and using θf ≈ 1− θg, since θpr << 1,
upr =
(1− θg)
1 + (r − 1)θguf −
Do
1 + (r − 1)θg
(




The continuity equation for protein is
∂θpr
∂t
+5 · (uprθpr) = Rxn(θpr). (5.5)
Here Rxn represents general reaction terms for reactions that change cpr. We are interested
in rewriting Equation 5.5 in terms of cpr, the amount of protein per total volume. Let Vpr
be the volume of a mole of protein. Then cpr = Vprθpr, and
∂cpr
∂t
+5 · (uprcpr) = Rxn(cpr) (5.6)
∂
∂t




1 + (r − 1)θgufθf c˜pr −
Doθf c˜pr
1 + (r − 1)θg
(























1 + (r − 1)θg 5 cpr
}
+Rxn.
We identity the hindrance terms to be
Hu =
(1− θg)
1 + (r − 1)θg (5.10)
Hd =
1
1 + (r − 1)θg (5.11)
uvol =
1
1 + (r − 1)θg
5(1− θg)
1− θg . (5.12)
Here, Hu accounts for the drag a protein feels from the presence of a gel, Hd accounts for the
reduced diffusion of protein because of the presence of gel , and uvol is a velocity term that
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moves proteins from regions of high gel volume fraction to regions of low volume fractions
at a rate proportional to the gradient of gel volume fraction.
Next, we look at the reaction terms by following unpublished notes by Fogelson [10].





Let Ω be a domain with volume VΩ. The above reactions occur only in the fluid, therefore
the concentration that appears in mass action terms should be the concentration per solvent
volume; c˜i, c˜j , and c˜k. The equations which describes the rate of change of the number of




ck = (k+c˜ic˜j − k−c˜k) θfVΩ. (5.14)
Then substituting cn =
c˜n
θf

















cicj − k−ck. (5.16)
For bimolecular reaction, the reaction rate is scaled by the volume fraction of fluid. For
degradation reactions and other reactions involving only one protein, there is no scaling.
We perform the same analysis on trimolecular reactions and find that the reaction rate must





kcat−−→ P + E, (5.17)
we can follow the same analysis as above and the standard quasi-steady state reduction to









We use the analysis above to modify the equations in Chapter 2 to include a coefficient
describing resistance to fluid advection, Hu,i, a coefficient describing hindered diffusion, Hd,i
and a new advection term that moves proteins due to a gradient in volume fraction, uvol,i.
Here i ∈ {z, f, c}. The subscript z is used for the prothrombin and thrombin equations.
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The subscript f is used for the fibrinogen equation. The subscript c is used for the gelation
equations. This choice is consistent with the assumption that diffusion it not dependent on
oligomer size. The complete list of equations is given in Appendix C. Below is the modified
equation for R as an example for the reader.
∂R(x, t)
∂t
+ ∇ · (Hu,cuRs) +5 · (Dcuvol,cRs) (5.19)











. The boundary conditions for R along the top and bottom walls are
also modified to include the additional flux terms. Define vvol,i to be the component of
uvol,i in the x2-direction. Because the right boundary condition is nonphysical and the left
boundary condition is not dependent on flux, they are not altered.
R(0, x2, t) = 0, (5.20)
∂R(Lx1 , x2, t)
∂x1
= 0, (5.21)














5.2.1 Ratio of Drag Coefficients
The parameter, r, is the ratio of the drag coefficients between fluid and protein and
gel and protein. We find this parameter for each protein type using data published, figure
22.7 in ([41]) where the diffusivities of macromolecule tracers were calculated as a function
of the volume fraction of fibrin. Two of the macromolecule tracers used were 70 kDa and
500 kDa, which are similar to the size of prothrombin (72 kDa) and fibrinogen (340 kDa),
respectively. We use these experimental data to estimate rz and rf . Because oligomers are





Figure 5.1 shows the values of r calculated by fitting a line to experimental data from ([41]).
We find
rz = 26.55φg + 1 (5.25)
rf = 47.53φg + 1. (5.26)
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φg





















Figure 5.1: Drag coefficient ratio for hindered transport. The top plot shows the value
r as a function of volume fraction of gel. The solid line is data, the dash line is a linear
fit. The bottom plot shows Hd as a function of φg using the linear equation for r. In both
plots, red and blue use data for macromolecules that are 70 kDa and 500 kDa, respectively.
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5.3 Results
We look at events in the blood vessel segment of length 400µm and height 100µm. In the
injury zone, there are two separated “bumps” with high Brinkman coefficients. Thrombin
is produced along the bottom vessel wall where the bumps are located. The Brinkman
coefficient distribution and spacial dependence of α is shown in Figure 5.2.
For the simulations described below, γ = 10s−1 and kb = 1µM−2s−1. The volume
fraction of the gel is a function of the fibrin mass density, we take
φg = NaVfθg, (5.27)
where Na is Avogadro’s number, Vf is the volume of a single fibrin molecule. In order to
decrease computational time, we take
φg = 50NaVfθg, (5.28)
to increase the influence fibrin mass has on the hindered transport coefficients and velocities.
We compare the hindered transport model with a baseline model, where Hd,i = 1,
Hu,i = 1, and uvol,i = 0 for i ∈ {z, f, c}. Initially, the two models behave similarly. Once a
gel appears the diffusivity and advection of proteins inside of the gel is lowered. This causes
a decrease in the source rate of fibrin monomer. Figure 5.3 shows how the spatial-average of
the fibrin source rate varies over time for simulation with the two models. The two curves
diverge once the gel begins to hinder the transport of prothrombin, thrombin, and fibrino-
gen. Figure 5.4 shows the fibrinogen and thrombin concentration and the monomer source
rate distributions for both models. It also includes the difference between them (baseline
concentrations minus hindered transport concentrations). Figure 5.5 shows the branch point
density in sol and the branch point and fibrin mass densities in the gel for both models as
well as their difference. Both figures are taken at t = 75s. At this time, two gels have
formed in the areas where the Brinkman coefficient is highest. The high density of fibrin
mass in the gel affects the transport of the proteins. Figure 5.4 shows that in the hindered
transport model, the fibrinogen concentration is higher outside of the gel than in the baseline
model. This is due to fibrinogen’s hindered diffusivity. Because the thrombin concentration
is lowered on the exterior of the gel and the fibrinogen concentrations are lowered inside
the gel, the fibrin source rate is slower almost everywhere as compared with the baseline
model. Figure 5.4 shows that in particular there is a significant reduction of fibrin source
inside of the gel near the wall. In regions with the highest fibrin mass densities, the diffusion
coefficients for fibrinogen and fibrin oligomers are lowered by almost 75%. Figure 5.5 shows
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Figure 5.2: Spatial dependence of thrombin production rate and Brinkman coeffi-
cient. Top: Thrombin production rate along the bottom wall with maximum value of
10−5 cmµMs−1. Bottom: Brinkman coefficient distribution.
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Figure 5.3: Average source rate with hindered transport. The spatial-average of the fibrin

































































































































































Figure 5.4: Thrombin, fibrinogen and source rate distributions with hindered transport.
Top: Thrombin distribution in µM . Middle: Fibrinogen distribution in µM . Bottom:
Source rate of fibrin monomer in µM/s. From left to right, baseline concentrations, hindered










































































































































































Figure 5.5: Branch point density and fibrin mass density distributions with hindrance.
Top: Branch point density distribution in sol in µM . Middle: Branch point density
distribution in the gel in µM . Bottom: Fibrin mass density in gel µM . From left to right,
baseline concentrations, hindered transport concentrations, and the difference between the
two. t = 75s
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that in the center of the gel there is a lower branch point density and fibrin mass density
for the hindered transport model than for the baseline model. The lower densities are due
to a decrease in the source rate of fibrin monomers. Proteins are moved out of the region
of high fibrin mass densities in the gel.
The velocity uvol moves proteins away from areas with a high volume fraction of gel.
Figure 5.6 shows the velocity vectors for uvol,c and the distribution of fibrin mass density in
the gel at t = 75 s. The maximum value of uvol is 0.1403µm/s which is on the same order
of magnitude as the horizontal fluid velocity within the gel.
The magnitude and direction of uvol are functions of the gradient of the volume fraction
of gel. The volume fraction of gel is highest at the bottom vessel wall and decreases as
one moves toward the center of the vessel so the vertical component of uvol is generally
pointed upward. The horizontal component points outward from the local maximum volume
fraction. Along the lower wall, where the fibrin density is highest, uvol appears to be
essentically zero (no velocity vector is visible). The vectors actually point downward and
to the left but are not visible in the figure. It should be noted that due to the boundary
condition (which includes the flux terms attributed to uvol), proteins do not cross the
boundary.
We have presented a model of fibrin polymerization which includes hindered transport
due to the resulting gel. This is dynamically a more realistic model of the gelation process
than the model described in Chapter 2. However, this modified model is not fully explored
here and is shown more as a proof of concept. There are several possible attributes of
the model that cause concern. Because the fluid velocity and uvol are on the same order
of magnitude, it is possible that summing their components, as one does when advecting
proteins, can result in enhanced motion, hindered motion, or no net motion. If there is no
net motion, this can result in an accumulation point. Accumulation points are a concern
because the hinder transport model has a singularity when the volume fraction of fluid is
zero. The model needs to be further tested to verify its validity and limitations, especially



















Figure 5.6: Hindrance velocity in a fibrin mass density distribution (µM). The vectors




To simulate the models described in the previous chapters, we use finite difference and
finite volume methods. Toward that purpose, we discretize the domain Ω using an Nx×Ny
Cartesian grid with equal spacing h in the x1 and x2 directions. Figure 6.1 shows the grid
and the indexing conventions used throughout this chapter for a generic concentration c. the
time step is denoted k. Let cn(x) denote the numerical approximation to the exact solution
c(x, nk) at grid points x. The independent variable z is discretized using Nz variably spaced
points.
The modified Navier-Stokes equations are simulated using a finite-difference-based pro-
jection method. For these equations, a Marker-and-Cell (MAC) grid is used. The x1
component of the fluid velocity is defined at the centers of the left and right (LR) cell
edges, and the x2 component of the velocity is defined at the centers of the top and
bottom (TB) cell edges. The pressure is defined at the center of cells. The coagulation
and gelation equations are discretized with finite-difference and finite-volume methods. All
concentrations are defined at the cell centers.
During each time step of size k, the following steps occur
1. Fluid velocities with an updated Brinkman term are calculated using a second-order
projection method.
2. The discretized coagulation equations for z2, e2, and f , are updated using Leveque’s
High-Resolution Advection Algorithm for advection, Alternating Direction Implicit
method (ADI) for diffusion, and second-order Runge-Kutta (RK) for reactions to
obtain a source rate of fibrin monomer, S10.
3. For the equations for W,R, and V , Leveque’s algorithm is used for advection in x,
ADI is used for diffusion in x, and a weighted average of Lax-Wendroff and Beam
Warming is used for advection in the dummy variable z in the W and V. Reaction










Figure 6.1: The computational mesh used for the numerical schemes described in this
chapter. The bold line marks the boundary of the domain. Outside of the boundary there
is one level of ghost cells. The value of c at the lower wall (x1 = 0) is labeled as cj−1,0.
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(a) The advection in the z variable for W is calculated first using Lax-Wendroff and
Beam Warming.
(b) W at z = 1 is not changed by advection in x or by diffusion. It can be calculated
from (a) and using Forward Euler for reaction terms.
(c) Using W at z = 1, Leveque’s Algorithm is used to calculate advection in x for
z < 1. Then ADI is use to calculate diffusion in x for z < 1.
(d) With Rg = −W |z=1, the above methods are used to update R. Then Rs =
R−Rg.
(e) Finally, V is updated using the same methods as used for W .
4. The structure variables, θs and Bs, are calculated by integrating W and V using the
trapezoid rule. Then θ can be calculated explicitly by applying a discrete advection
and diffusion operator to θs and using Forward Euler for the reaction terms. Since
Bg = Rg, B is calculated using simple addition, B = Bs +Bg.
5. The Brinkman term is updated as are φg, and the hindered diffusion and hindered
advection terms from the hindered transport model.
6. Repeat until desired time is reached.
In the sections below, we describe the numerical methods used in more depth. We begin
with the modified Navier-Stokes equations.
6.1 Fluid
We use finite differences and an exact projection method to find approximate solutions
to equations 2.43-2.44. First, we solve a linear system to find an intermediate velocity value,
u∗, using the momentum equation. Then we solve a Poisson problem for the pressure and
use it to correct u∗ to un+1 which is discretely divergence free.

















The term ∆h is the discrete 5-point Laplacian operator. In the Brinkman term, u∗ is used
instead of un for numerical stability. Equation 6.1 is a linear system for u∗. In order to
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solve this system, we use the iterative method, Successive Overrelaxation (SOR). The value
u∗ does not satisfy ∇h · u∗ = 0, where ∇h· is the discrete divergence operator defined in
detail below.
Next, we take u∗ to un+1 using the pressure gradient. We discretize the remaining terms




∇ · un+1 = 0, (6.4)
Here ∇h is the discrete gradient operator and is defined in detail below. Rearranging
Equation 6.3, we see that un+1 is a projection of u∗ onto the divergence free velocity field.
We apply the discrete divergence operator to both sides of Equation 6.3 and use Equation




∇h · u∗. (6.5)
This is a Poisson equation for p. A multigrid method is used to solve this equation. The
multigrid method uses red-black Gauss-Seidel as the smoothing operator, full weighting as
the restriction operator, and bilinear interpolations as the prolongation operator. Once we
have obtained p, we compute un+1 as
un+1 = u∗ + k∇hp. (6.6)
The discrete divergence operator takes a vector defined on the cell edges and returns a
scalar located in the center of the cell. When applied to u∗ in cell (i, j), the result is



















The discrete gradient operator takes scalar values located in the cell centers and returns











We use the Peaceman-Rachford [31] version of the ADI method to model diffusion in
our 2-D physical domain. Like Crank-Nicolson, ADI is a second order method; however,
ADI is a 2-step method. In each step of ADI, one direction of diffusion is modeled explicitly
while the other direction is modeled implicitly. The roles reverse in the successive step.





We begin with treating diffusion in the x2 direction implicitly and diffusion in the x1
direction explicitly. The complexity of the nonlinear Robin condition in z2 dictates this
choice at the x2 = 0 boundary. The steps used to obtain c
n+1 from cn are
(I − k
2














D∇2h,x2)c∗ = (I +
k
2
D∇2h,x1)cn + k(Advx + Advz + Rxn) (6.13)
(I − k
2




Here Advx is the advection term in x calculated from Leveque’s Algorithm, Advz is the
advection term in z calculated using Lax-Wendroff and Beam-Warming, and Rxn is the
reaction term treated with either Forward Euler or Runge-Kutta as noted in the algorthim
list at the beginning of this chapter.
In order to solve Equations 6.13-6.14, we extend the discrete varible c to a larger domain
that includes one level of ghost cells on all 4 edges. This is accomplished using the boundary
conditions. Since the boundary itself is midway between cell-centers (-1, j) and (1, j), we set
the ghost cell value c -1,j so that the average of c1,j and c -1,j is c
up, i.e. c -1,j = 2 c
up−c1,j . For
the top wall and downstream boundary, the homogenous Neumann boundary condition is
discretized using centered differencing and used to fill in the appropriate ghost cells values,
ci,Nx2+1 = ci,Nx2 (6.15)
cNx1+1,j = cNx1 ,j . (6.16)
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For f and the gelation variables, the homogenous Neumann boundary conditions along the
bottom wall is also discretized using center differencing and used to fill in the ghost cell
values,
ci, -1 = ci,1. (6.17)






requires more work. For ease of notation, let z2(ih, jh, nk) = Z
n














The left side of Equation 6.19 involves center differencing about x2 = 0. For right side, the





and Zni,2) at the current time level. In the denominator, Zi,0 is approximated using quadratic
interpolation at the previous time step. After some algebraic manipulation, one can find
an expression for Zi, -1 as a function of values at interior grid points of Z. The boundary
condition along the bottom wall for e2 is the same as that for z2 except for a sign change on
the right hand side. Numerically, we maintain consistency by using the same approximate
values for Zi,0 in e2 as in the boundary condition for z2, namely
−Dz
(







where Zni,0 and Z
n−1
i,0 are as just described.
The equations for W and R, must be written in the form of the Equation 6.10 in order
to use ADI. As a reminder for the reader, the evolution of W is described by
∂W
∂t
= ∇ · (Dc∇ (W − zW ∣∣z=1))+ ∆t(Advx + Advz + Rxn). (6.21)
Splitting the diffusion term,
∂W
∂t







Let W (ih, jh, kn, zl) = W
n
i,j,l, where {zl}, l = 0, 1, ..Nz are discrete grid points on the
z-interval [0, 1]. By this stage in which we update W to account for diffusion in x, we have
already updated W to account for advection in z so Wn+1i,j,Nz is known. We apply a five-point
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For W , the ADI method is modified to
(I − k
2







+ k(ADVx + ADVz + Rxn). (6.23)
(I − k
2




The diffusion term for R is rewritten by making the substitution Rs = R−Rg,
∂R(x, t)
∂t
= ∇ · (Dc∇ (R−Rg)) + k(ADVx + Rxn). (6.25)
As for W , the ADI method for diffusion of R is modified to include Dc∇2Rg, discretized
with a 5-point Laplacian on the right hand side of the first step.
(I − k
2
Dc∇2h,x2)R∗ = (I +
k
2
Dc∇2h,x1)Rn − kDc∇25hRg (6.26)
+ k(Advx + Advz + Rxn)
(I − k
2




In order to apply the 5-point Laplacian stencil over the whole domain, Rg must be
extended to one level of ghost cells around the domain x. Because Rg does not advect
or diffuse, it does not have a boundary condition. Therefore, Rg is extrapolated to each
ghost cell by fitting a polynomial to the first three interior points along the normal to the
boundary.
Finally, the ghost cells values for R are filled in using the boundary conditions for Rs and
Rg. Rs has homogenous Neumann boundary conditions along the top and bottom walls. As
before, we approximate the normal derivatives using a centered difference at the boundary.
The ghost cells for R must satisfy R = Rg + Rs and are filled accordingly. The upstream
boundary condition is R = 0. We set the ghost cell value, R -1,j so that the average of R1,j
and R -1,j is identically zero.
The homogenous Neumann downstream boundary condition is discretized using center
differencing and used to fill in the ghost cell values on the right boundary.
6.3 Advection in x
Advection in the x domain is handled using Leveque’s conservative algorithm for advec-
tion [22]. This algorithm begins with the upwind method then offers a series of corrections
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+∇ · (uc) = 0. (6.28)
From the fluid solver, velocities are located at cell edges (unlike concentrations which are
located at cell centers). This shown in Figure 6.2. Let u be the fluid velocity in the
x1-direction and v be the fluid velocity x2-direction. We now calculate the flux into cell
(i, j). Let Fi−1/2,j and Fi+1/2,j be the fluxes to the right across the left and right cell
edges, respectively, of cell (i, j). Similarly, Gi−1/2,j and Gi+1/2,j are the upward fluxes
across the bottom and top edges of the cell. Although LeVeque’s algorithm can handle
velocity components of either sign, for simplicity, we describe if for the case ui±1/2,j > 0
and vi,j±1/2 > 0. To begin with, we apply the upwind method over all i, j,
Fi−1/2,j = ui−1/2,jci−1,j (6.29)
Gi,j−1/2 = vi,j−1/2ci,j−1. (6.30)
We can improve on the upwind fluxes by accounting for transverse propagation. The
transverse propagation in the x1 direction affects the flux through the top and bottom
of the cell, and that in the x2 direction affects the fluxes across the left and right cell edges.
Gi,j−1/2 = Gi,j−1/2 +
1
2
ui−1/2,jvi−1/2,j (ci,j − ci−1,j) , (6.31)
Fi−1/2,j = Fi−1/2,j +
1
2
ui,j−1/2vi,j−1/2 (ci,j − ci,j−1) . (6.32)
Currently, as described this is a first-order method with higher accuracy than the upwind
method alone. Equations 6.31-6.32 are further corrected using the Lax-Wendroff method
with a flux-limiter. Lax-Wednroff is a second-order method but creates oscillations when
there are steep gradients. Therefore, we use a flux-limiter, Φ.
Fi−1/2,j = Fi−1/2,j +
1
2
∣∣ui−1/2,j∣∣ (1− kh ∣∣ui−1/2,j∣∣
)
(ci,j − ci−1,j) Φ1,(i,j) (6.33)
Gi,j−1/2 = Gi,j−1/2 +
1
2
∣∣vi,j−1/2∣∣ (1− kh ∣∣vi,j−1/2∣∣
)
(ci,j − ci,j−1) Φ2,(i,j), (6.34)
where Φ1,(i,j) = φ(θ1,(i,j)) and Φ2,(i,j) = φ(θ2,(i,j)). The function φ can be any for a number
of flux-limiter methods including monotonized centered, superbee, or minmond. The value
of θ1,(i,j) and θ2,(i,j) are each ratios of approximate first derivatives of c in the x1 and x2
directions using cells neighboring the i, jth cell.
θ1(i,j) =
cI − cI−1
ci,j − ci−1,j , (6.35)
I =
{
i− 1, j if ui,j > 0







Figure 6.2: M.A.C. grid. Fluid velocities, u, are located at cell edges and are used to
calculate the flux of c into cell i, j. Concentrations, c, are located at cell centers.
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The argument θ2,(i,j) function of Φ2,(i,j) is defined similarly but using differences in the
x2 direction. If the gradient is steep, θ = 0 and equations 6.33 - 6.34 reduce to the upwind
method. If the gradient is not steep, 6.33-6.34 is close to the Lax-Wendroff Method. Next,
we add a correction to account for the transverse propagation of these second-order fluxes,





∣∣ui−1/2,j∣∣ (1− kh ∣∣ui−1/2,j∣∣
)
(ci,j − ci−1,j) Φ1,(i,j),
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(ci,j − ci,j−1) Φ2,(i,j).































6.4 Advection in z
The equations for W and V each contain a term that describes advection in z. We
know from similar models [42] that W experiences a singularity (Wz|z=1 →∞) at z = 1 at
the time tg when a gel first appears. We refer to tg as gel time. W is always smooth for
0 ≤ z < 1 and W is smooth at z = 1 except at t = tg. The advection velocities in z for
W and V are positive for information propagating from left to right. Therefore, we use a
modified Beam-Warming method which is a one-sided, second-order method to handle the
z-advection [23]. Given an equation of the the form,
∂c
∂t
+ f(c)z = 0, (6.43)
Here f(c) is some functional dependence on c. The modified Beam-Warming method is
cn+1i = c
n









if f(c)z is approximated with a one-sided second order finite-difference. Due to the
definition of W and V , they are zero at z = 0 for all time. The first interior point value,
c1, is found using first-order upwinding.
Because Rg is defined as W at z = 1, it is important to be accurate at this point.
We achieve this level of accuracy, while keeping our computational cost low, by using













hi−1(hi+hi−1) , bw2 = −
hi+hi−1
hi−1hi , and bw1 = −(bw3 + bw1). Let AdvBW,i =
bw1 f(c)
n
i − bw2 f(c)ni−1 + bw3 f(c)ni−2.
Using the above method, W and V at z = h1, is found using only a first-order method.
However, we are interested in integrating W and V in z from [0, 1]. In order to obtain a more
accurate value of V,W , we use a linear combination of Lax-Wendroff and Beam-Warming.
Lax-Wendroff is a two-sided, second-order method that models advection [23]. For an



















































































We then define Advz by
Advz,i = AdvLW,i(1− 0.5 tanh(20(zi − 0.25))− 0.5) (6.49)
+ AdvBW,i(0.5 tanh(20(zi − 0.25)) + 0.5).
For values of z near 0, this advection term is essentially that from the Lax-Wendroff
Method. For values of z near 1, is is essentially that from the Beam-Warming Method.
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{ {hi 1 hi
Figure 6.3: Nonuniform z-grid for beam-warming method. The Beam-Warming method is
a one-sided method. In order to achieve a more accurate computation of Rg, the z dimension
has nonuniform spacing with point space more closely near z = 1. This is an example of
the nonuniform spacing of z ∈ [0, 1] with the number of points, Nz = 100.
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6.5 Reactions
A secord-order, two-step Runge-Kutta method is used to treat the specified reactions
[23]. We illustrate the method on the sample equation,
∂c(x1, x2)
∂t
= Rxn (c (x1, x2)) , (6.50)
where Rxn (c (x1, x2)) is a function of reaction terms that involve only quantities in (x1, x2).
Beginning at time level n,we advance cn to cn+1 using the following method,




cn+1 = cn + kRxn(c∗). (6.52)
CHAPTER 7
CONCLUSION
In this dissertation, we present a two-dimensional model of fibrin polymerization and
gelation in flow with feedback on the fluid. The model includes a spatial-temporal source
of fibrin monomers from a simplified coagulation model and a polymerization process based
on the Branching Model [11]. The polymerization submodel begins with a doubly-infinite
set of PDEs that describes the transport of oligomers and condensation reactions between
fibrin oligomers. Through the use of a generating function and a change of variables, we
are able to reduce the system to two PDEs (W and R). It is necessary to add two dummy
variables in order to perform this reduction, one of which we are able to take as a constant
value. We include three other PDEs, V , B, and θ, and three algebraic expressions that
enables us to track the branch point density and fibrin mass density in the gel (as well
as concentrations in the solvent). Branch point density and fibrin mass density are used
to calculate the gel’s structural properties which, in turn, provide feedback on the fluid
through a Brinkmann term.
Through numerical simulation with and without fluid flow, we are able to examine the
process of fibrin clot formation. Most importantly, we see that fibrin gel cannot form along
a flat wall. It is essential to have a region protected from flow for clots to form. Biologically,
this protected region could be from small platelet aggregates, which are necessary for
thrombin production, or other cells that bind to the blood vessel wall. We add an area
upstream of the injury that has low permeability which we call a “bump” to simulate clot
growth in flow.
We find that the branch point density, fibrin mass density, and structural properties of
a clot are dependent on several conditions during gelation, one of which is the source rate of
fibrin monomers. Clots formed with fluid velocity identically zero have three distinct areas.
Near the wall, there is an inner core with the smallest fibers and smallest pores that is a
result of a high initial source rate. Just outside of the inner core, there is a shell of medium
fiber diameters and pores that results from the depletion of fibrinogen and prothrombin at
the wall. Outside of the shell, there is a small area of fibers that have just become gel. In
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this area, there are large pores and medium fiber diameters. In flow, the fluid dynamics
affect the distribution of the fibrin monomer source rate. By adding an area with a high
brinkman coefficient, we create a region over the injury zone where the Pe´clet number is
less than one. This region is larger for low shear rates. For all shear rates attempted, there
is enough fibrin monomer accumulation that a gel can form over the injury zone. Within a
single clot made in flow, the fiber diameter and pore sizes have little variability.
We find that the rate of thrombin production, α, affects initial thrombin production but
does not affect the width or height of the resultant clot. Without flow, a high thrombin
production rate causes a smaller fiber diameter near the vessel wall than a smaller rate.
However, it has little influence on the fiber diameters away from the wall because the pro-
duction of thrombin becomes diffusion limited. In flow, we change the thrombin production
rate by several orders of magnitude and see only a small variation in fiber diameter.
The rate of branch point formation has a significant effect on both the clotting time and
the resulting clot structure. Gels formed with a larger kb, grow faster, have smaller fiber
diameters, and have smaller pores. We also show that the biological upstream fibrinogen
concentration is necessary for normal clotting. When the upstream fibrinogen concentration
was decreased by a factor of two, clots took significantly longer to initiate. When the
upstream fibrinogen concentration was decreased by a factor of 10, there was no clot
formation within 2000 s, with or without flow. There must be a significant accumulation of
branch points in order for gelation to occur.
We modify the model in two ways. We simulate thrombin production on platelet
aggregates that are located in the fluid. We show that several different distributions of
platelet aggregates provide the necessary region protected from flow for fibrin gelation to
occur. We also modify the model to include more realistic transport dynamics. Realistically,
as the gel accumulates, the diffusivity of proteins decrease so we include a coefficient
that hinders diffusion of proteins as a function of gel volume fraction. Also, the drag on
proteins as they advect past gel increases with increasing gel volume fraction so we include
a coefficient to hinder the advection flux of proteins in relation to gel volume fraction. We
also include a third component to the hindered transport model which creates a velocity
that moves proteins out of areas with high gel volume fraction and into areas with low
volume fraction.
While this dissertation studies the process of fibrin polymerization in flow, it does not
provide a complete understanding of the complex interplay between coagulation, fibrin
gelation, and fluid dynamics. Several extensions and future works have previously been
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mentioned in this paper including further understanding of the hindered transport model,
exploring the dynamics necessary to include the lateral aggregation of protofibrils, and
possibly a completely different type of model to study fibrin orientation in flow.
The framework for at least one possible extension was laid out in Fogelson et al. 2015
[12]. Physically, each k-mer has a diffusivity that is related its size and structure. In the
models described in this dissertation, all oligomers have the same diffusivity. Fogelson et
al. show it is possible to include any finite number of oligomers diffusing with different
diffusivities. However, in this model framework, for each additional oligomer diffusion
coefficient included, a PDE for the respective k-mer must be added to the system and the
diffusion coefficients for the variables in the current model become more complicated. It is
more realistic to include two different diffusivities: monomers maintain the same diffusivity
as fibrinogen and larger oligomers have a smaller diffusivity or are stationary.
In the author’s opinion, the most obvious and necessary extension to this work is
to couple the fibrin polymerization model with a model for coagulation and platelet ag-
gregation. Both fibrin and platelets are primarily components of a thrombus. Platelets
play an important spatial and temporal role in thrombin production that is essential for
fibrin polymerization. Fibrinogen is also a necessary component of platelet aggregation.
Fibrinogen connects two platelets by binding to αIIbβ3 integrins receptors located on
the membrane of platelets [3]. Fibrin gel also provides necessary structural support that
prevents the thrombus from embolizing. The fibrin polymerization model can be combined
with a two-dimensional model of the coagulation cascade and platelet aggregation such as
[21]. As platelets aggregate, they hinder the flow around the injury zone. With sufficient
hindrance on the fluid flow and thrombin production, fibrin polymerization can occur.
APPENDIX A
FIBER DIAMETER AND PORE SIZE
From the model described in Chapter 2, we are able to track branch point density and
fibrin mass density. We use a geometric argument to find a mathematical relationship be-
tween these densities and structural properties of the gel (i.e., pore size and fiber diameter).
The reader should imagine a 2-D domain filled with fibers that are connected by branch
points. If all the fibers are of equal length and equally spaced apart, the domain would
be tessellated with hexagon where branch points are the vertices and fibers are the edges,
shown in Figure A.1.
We focus on the area around a single branch point denoted by a green triangle in Figure





(P + 2r) . (A.1)











Here Na is Avogadro’s number. The area of fiber, Af , in the green triangle is approximately,
Af = 3(P + a)a. (A.4)





We can find the volume fraction of fibers in the model from the fiber mass density,
φg = NaVfθg. (A.6)
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Figure A.1: Idealized branch point and fiber networks. Branch points represented by red
dots. Fibers are blue lines.
Figure A.2: Area around a single branch point. The length of the pore is P , the radius of
a fiber is r.
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Here Vf = 4.2 × 10−19 cm3 is the volume of a single fibrin monomer. We are left with
































Table B.2: Coagulation parameters. a) The cleavage rates of prothrombin to thrombin
were tuned to be within ranges that match from [29].




α 1× 10−5 cmµM/s a






Dz 1× 10−7 cm2/s e
Df 1× 10−7 cm2/s f







Dc 1× 10−7 cm2/s
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The following equations are used to describe fibrin polymerization and gelation with
hindered advection and hindered diffusion. The term Hu,i is the hindrance due to drag
between gel and proteins in the fluid. The term Hd,i describes how much diffusion is
hindered due to the presence of gel, and uvol,i describes the transport of proteins out of
a volume due to occupation by gel. Here i ∈ {z, f, c}. The exact form of the hindrance
terms are described in Chapter 5. The boundary conditions along the top and bottom wall




+∇ · (Hu,zuz2) +5 · (Dzuvol,zz2) = ∇ · (Hd,zDz∇z2) (C.1)
∂e2
∂t
+∇ · (Hu,zue2) +5 · (Dzuvol,ze2) = ∇ · (Hd,zDz∇e2)− kate2 (C.2)
∂f
∂t
+∇ · (Hu,fuf) +5 · (Dfuvol,ff) = ∇ · (Hd,fDf∇f)− kfe2f
φfkfs + f
. (C.3)
With the following boundary condition:
For z2,
z2(0, x2, t) = z
up
2 , (C.4)
∂z2(Lx1 , x2, t)
∂x1
= 0, (C.5)






















e2(0, x2, t) = 0 (C.8)
∂e2(Lx1 , x2, t)
∂x1
= 0, (C.9)











e2, for x1 < L1, x1 > L2
αz2
Hd,z(φfβ+z2)
− Dzvvol,zHd,z e2, for L1 ≤ x1 ≤ L2.
(C.11)
For f ,
f(0, x2, t) = f
up, (C.12)
∂f(Lx1 , x2, t)
∂x1
= 0, (C.13)


















+ ∇ · (Hu,cuRs) +5 · (Dcuvol,cRs) (C.15)







R3 − (3RsR2g +R3g))+ 2S˜10
Boundary Conditions for R,
R(0, x2, t) = 0, (C.16)
∂R(Lx1 , x2, t)
∂x1
= 0, (C.17)


















+ 5 · (Hu,cu (W − zW ∣∣z=1))+5 · (Dcuvol,c (W − zW ∣∣z=1)) (C.20)























(−zR3 + 3zRsR2g + zRg3)+ kb2φ2f z2R3
Boundary Conditions for W,
W (0, x2, t, z) = 0, (C.21)
∂W (Lx1 , x2, t, z)
∂x1
= 0, (C.22)




























+ 5 · (Hu,cuV ) +5 ·Dcuvol,cV (C.26)


















(W + zR)2 (Wz +R)
}
+ 2zS10.
Boundary Conditions for V,
V (0, x2, t, z) = 0 (C.27)
∂V (Lx1 , x2, t, z)
∂x1
= 0 (C.28)

















+ 5 · (Hu,cuθs) +5 ·Dcuvol,cθs (C.33)
= 5 · (Hd,cDc 5 θs) + S˜10
Boundary Conditions for θ,
θ(t, 0, y) = 0 (C.34)









(θ − θg) (C.36)











+ 5 · (Hu,cuBs) +5 ·BsDcuvol,c (C.39)
= 5 · (Hd,cDc 5Bs) + kb
6φ2f
(
R3 − (3RsR2g +R3g))
Boundary Conditions for B,
B(t, 0, y) = 0 (C.40)
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